User:Colin/ExistingPrices

This page contains extracts of cost or price information from 530 drug articles as of 30 Dec 2019.

Abacavir
The wholesale cost in the developing world as of 2014 is between US$0.36 and US$0.83 per day. As of 2016 the wholesale cost for a typical month of medication in the United States is US$70.50.

Abacavir/lamivudine
The wholesale cost in the developing world is about US$14.19 to $16.74 per month as of 2014. As of 2015 the cost for a typical month of medication in the United States is more than $200.

Abiraterone
In the United Kingdom it costs the NHS £2,735 a month as of 2018. In the United States this amount costs US$3,276 as of 2019. The medication is marketed widely throughout the world.

Cost
In the United Kingdom it costs the NHS £2,735 a month as of 2018. In the United States this amount costs US$3,276 as of 2019. A generic version is available in India at a price of US$238 a month as of 2019.

Acetaminophen/butalbital
In the United States the wholesale cost is about 1.20 USD per dose as of 2019.

Acetazolamide
The wholesale cost in the developing world is about US$1.40–16.93 per month. In the United States the wholesale cost is about US$125.34 per month.

Aciclovir
The wholesale cost as of 2014 to 2016 was between US$0.03 and US$0.12 for a typical dose by mouth. The cost of a typical course of treatment in the United States is less than US$25.

Cost
The wholesale cost for a 400 mg tablet in March 2016, was between US$0.03 and US$0.12 per dose.

Activated charcoal (medication)
The wholesale costs in the developing world is between US$0.46 and US$0.86 per dose. In the United States a course of treatment costs less than US$25.

Adalimumab
A month supply in the United Kingdom costs the NHS about £704.28 as of 2018. In the United States the wholesale cost of this amount is about US$5,041.12. In 2014, a biosimilar came to market in India at a price of US$400 per month.

Albendazole
The wholesale cost in the developing world is between 0.01 and US$0.06 per dose. In the United States, as of 2019, the wholesale cost is about US$128 per dose.

Cost
In many areas of the world it costs between US$0.01 and US$0.06 per dose. In the United States, however, it costs about US$50 per dose, as of 2014. In Raleigh, North Carolina, the brand-name prescription cost was around US$800, and US$540 for the generic. The pharmaceutical company Amedra increased the price after purchasing the rights to the drug, instead of lowering it as generics are predicted to do, drawing criticism from patients' rights advocates and US Democratic Party leaders.

Alcohols (medicine)
The wholesale cost in the developing world is about US$1.80–9.50 per litre of 70% denatured ethanol. In the United Kingdom it costs the NHS about 3.90 GBP per liter of 99% denatured alcohol.

Alendronic acid
In the United Kingdom, a month of medication costs the NHS about 0.41 pounds as of 2019. In the United States, the wholesale cost is about US$1.16 per month.

Allopurinol
The wholesale cost in the developing world is about US$0.81–3.42 per month. In the United States a month of treatment costs less than $25.

Alprazolam
The wholesale cost in the United States is less than US$0.03 per dose as of 2018. In 2016, it was the 19th most prescribed medication in the United States, with more than 27 million prescriptions.

Alteplase
In the United Kingdom it costs about £864 per treatment as of 2018. In the United States this amount costs about US$9,197 as of 2019.

Society and culture
In the United Kingdom it costs about £864 per treatment as of 2018. In the United States this amount costs about US$9,197.

Amikacin
The wholesale cost in the developing world is 13.80 to US$130.50 for a month. In the United States a typical course of treatment costs 25 to US$50.

Amiodarone
In the developing world the wholesale cost as of 2014 is about US$0.06–0.26 per day. In the United States a typical month supply is between $100 and $200.

Amitriptyline
The wholesale cost in the developing world was between 0.01 and US$0.04 per dose. In the United States, it costs about US$0.20 per dose.

Amlodipine
Wholesale cost in the developing world is US$0.003 to 0.066 per day for a typical dose as of 2015. In the United States, a month's supply costs less than $25.

Amlodipine/benazepril
A month supply in the United States has a wholesale cost of about US$4.50.

Amodiaquine
The wholesale cost is about US$0.01 per dose as of 2014.

Amoxicillin
It has a wholesale cost in the developing world of between US$0.02 and $0.05 per pill. In the United States, ten days of treatment costs about US$16 ($0.40 per pill).

Amoxicillin/clavulanic acid
The wholesale cost in the developing world is about US$0.18–1.14 per day. In the United States a course of treatment costs $50–100.

Ampicillin
Its wholesale cost in the developing world is between US$0.13 and 1.20 for a vial of the intravenous solution as of 2014. In the United States, it is available as a generic medication and 10 days of treatment cost about $13.

Cost
, ampicillin's wholesale cost is between US$0.13 and 1.20 for a vial of the intravenous solution. In the United States, it is available as a generic medication: 10 days of treatment cost about $13.

Anastrozole
The wholesale cost in the developing world is about US$1.92–30.60 a month. In the United States the wholesale cost is about $3.81 per month.

Anti-tetanus immunoglobulin
The wholesale cost in the developing world for the horse version is about US$0.90–3.60 per 1500 iu vial, while the human version is US$10.00–46.86 for 250 iu. In the United States a course of treatment costs about $100–200.

Antivenom
Depending on the type, the wholesale cost in the developing world is US$9.00–US$118.80 per vial. In the United States, the wholesale cost is as high as $2,300 per dose.

Apixaban
A month supply in the United Kingdom costs the NHS about £57 as of 2019. In the United States the wholesale cost of this amount is about $427.

Aprepitant
In the United States it about US$230 per dose. This amount in the United Kingdom cost the NHS about £16.

Aripiprazole
In the United Kingdom, a month's supply costs the NHS about £2.75 as of 2019. In the United States, the wholesale cost of this amount is 10 USD.

Arsenic trioxide
In the United Kingdom it costs the NHS £292 a dose as of 2018. In the United States this amount costs about US$508 as of 2019.

Cost
In the United Kingdom it costs the NHS £292 a dose as of 2018. In the United States this amount costs about US$508 as of 2019. With initial treatment being 60 days the cost for a course of treatment is £17,520 and US$30,000 respectively.

Artemether
The wholesale cost in the developing world is between US$0.38 and US$16.47 per vial. The combination form costs between US$100 and US$200 for a course of treatment in the United States.

Artemether/lumefantrine
The wholesale cost in the developing world is between US$0.10 and US$1.2 per day as of 2014. It is not available as a generic medication and a course of treatment costs between US$100 and US$200 in the United States.

Artesunate
The wholesale cost in the developing world is US$2.09 to US$2.57 a dose.

Artesunate/amodiaquine
The wholesale cost in the developing world is about US$0.85 to US$1.52 for a course of treatment.

Asparaginase
The wholesale cost in the developing world is about US$42.00 per 10,000 IU vial. This amount in the United Kingdom costs the NHS 613.00 pounds.

Aspirin
, the wholesale cost in the developing world is US$0.002 to US$0.025 per dose. , the cost for a typical month of medication in the United States is less than US$25.00.

Atazanavir
The wholesale cost in the developing world is about US$15.72 per month. As of 2015, the cost for a typical month of medication in the United States was more than $200.

Atenolol
Atenolol was patented in 1969 and approved for medical use in 1975. It is available as a generic medication. In the United States, the wholesale cost per month is less than 15 USD as of 2018. In the United Kingdom, a month of treatment costs the NHS less than 5 pounds.

Atenolol/chlorthalidone
A month supply in the United Kingdom costs the NHS less than 2 £ as of 2019. In the United States the wholesale cost of this amount is about US$12.30.

Atomoxetine
A month's supply in the United Kingdom costs the NHS about £53 as of 2019. In the United States, the wholesale cost of this amount is about US$77.

Atorvastatin
In the United States, the wholesale cost per month is about 3.80 USD as of 2018. In the United Kingdom, it costs the NHS about £0.70 per month as of 2018.

Atovaquone/proguanil
In the United Kingdom it costs £2.10 per dose as of 2019. The wholesale cost in the United States is $US 2.82 per dose as of 2019.

Atracurium besilate
The wholesale cost in the developing world is about US$1.69–1.87 per dose.

Atropine
It is available as a generic medication and is not very expensive. A one-milligram vial costs between US$0.06 and US$0.44, wholesale, in the developing world.

Atropine/diphenoxylate
In the United States the wholesale cost per is dose is US$0.31.

Azathioprine
The wholesale cost in the developing world is about US$7.63–17.19 a month. The wholesale cost in the United States is about US$35.34 per month.

Azelastine
A 22 millilitre bottle in the United Kingdom costs the NHS about £10.50 as of 2019. In the United States the wholesale cost of this amount is about US$8.40.

Azithromycin
The wholesale cost in the developing world is about US$0.18 to US$2.98 per dose. In the United States, it is about US$4 for a course of treatment.

Cost
The wholesale cost is about US$0.18 to US$2.98 per dose. In the United States it is about US$4 for a course of treatment. In India it is about US$1.7 for a course of treatment

BCG vaccine
Between 2011 and 2014 the wholesale price was US$0.16 to US$1.11 a dose in the developing world. In the United States it costs US$100 to US$200.

Baclofen
A month supply in the United Kingdom costs the NHS about £1 as of 2019. In the United States the wholesale cost of this amount is about US$8.40.

Barium sulfate suspension
The wholesale cost in the developing world is about US$37.80–79.33 per kilogram. In the United States a course of treatment is not very expensive.

Beclometasone
The wholesale price in the developing world for an inhaler containing 200 doses of medication is about US$3.20 as of 2014. In the United States it costs US$50–100 for a typical month supply of the inhaled form.

Benazepril
A month supply in the United States costs about US$1.32 as of 2019.

Benzathine benzylpenicillin
The wholesale cost in the developing world is about 0.27 to 1.71 USD for a course of treatment. In the United States the medication costs 50 to 100 USD for a dose as of 2015. In the United Kingdom it costs the NHS about 0.95 to 1.89 pounds a dose as of 2015.

Benzatropine
In the United States the wholesale cost is about 6 USD per month.

Benzonatate
In the United States the wholesale cost of is about 0.12 USD per dose.

Benzoyl peroxide/clindamycin
Currently Duac costs $362.69 for 45 grams in the US (significantly less elsewhere, eg. $15 for 60 grams in Poland ) and Onexton costs $477.74 for 50 grams.

Benzyl benzoate
The wholesale cost in the developing world is about US$0.21–0.53 per 100 mL. In the United Kingdom it costs the NHS about £2.50 for 500 mL.

Benzylpenicillin
The wholesale cost in the developing world is about US$0.24–2.72 per day. In the United States a course of treatment costs $100–200.

Bevacizumab
The wholesale cost in the developing world is about US$638.54 per vial. This dose in the United Kingdom cost the NHS about £242.66 in 2015.

Costs
In countries with national health care systems (such as the UK and Canada), many of those national health services have restricted bevacizumab on the basis of cost-benefit calculations; in the U.K., for example, the National Institute for Health and Care Excellence has taken the position that bevacizumab should not be funded by the NHS because it costs nearly £21,000 per patient but only minimal benefit in many cancers. In 2006, the Scottish Medicines Consortium recommended against the NHS funding Avastin for first-line treatment of metastatic carcinoma of the colon or rectum, due to estimated costs of £24,000 to £93,000 per quality-adjusted life year (QALY). The addition of bevacizumab to standard treatment can prolong the lives of lung cancer patients by several months, at a cost of $100,000 a year in the United States. For colorectal cancer, Robert J. Mayer wrote in the New England Journal of Medicine that bevacizumab extended life by 4.7 months (20.3 months vs. 15.6 months) in the initial study, at a cost of $42,800 to $55,000. Costs in other countries vary; in Canada it is reported to cost $40,000 CAD per year. On September 16, 2014 Genentech reclassified bevacizumab as a specialty drug which are only available through specialty pharmacies. "Specialty drugs usually fall under the FDA’s Risk Evaluation and Mitigation Strategy (REMS) program, established for compounds like the testosterone... that may have unusual side effects; or for drugs that are unusually expensive." This has caused concern to hospitals as the price increased. According to IMS Health, the average price charged by hospitals for bevacizumab is approximately $9000 compared to approximately $2300 when administered in a doctor's office. As a result of the new distribution arrangement, many hospitals will no longer be eligible for the 51% discount to average wholesale price that was mandated by the Affordable Healthcare Act under the old distribution arrangement. When bevacizumab is used in the treatment of wet age-related macular degeneration (wet AMD), only tiny and relatively inexpensive doses (compared to amounts used in colon and other cancers) are required. Some investigators reported in 2010 that bevacizumab at a cost of around $42 a dose is as effective as ranibizumab at a cost of over $1,593 a dose.

Bicalutamide
The wholesale cost in the developing world is about US$7.07 to US$144.22 per month. In the United States it costs about US$10.00 and above per month.

Cost and generics
Bicalutamide is off-patent and available as a generic, and its cost is low in comparison to a number of other similar medications (from US$10.00 to US$15.44 for a 30-day supply of once-daily 50 mg tablets). Brand name Casodex costs US$556.17 for a 30-day supply of once-daily 50 mg tablets. Unlike bicalutamide, the newer NSAA enzalutamide is still on-patent, and for this reason, is considerably more expensive in comparison (US$7,450 for a 30-day supply ). Bicalutamide is considerably less costly than GnRH analogues, which, in spite of some having been off-patent many years, have been reported (in 2013) to typically cost US$10,000–$15,000 per year (or about US$1,000 per month) of treatment.

Bimatoprost
A 3milliliter bottle in the United Kingdom costs the NHS about 9.30 £ as of 2019. In the United States the wholesale cost of this amount is about US$80.

Biperiden
The wholesale cost in the developing world is about US$1.52–12.92 per month. In the United States it costs about $50–100 per month.

Bisoprolol
The wholesale cost in the developing world is about US$2.98–4.94 per month. In the United States, as of 2015, it costs about $25–50 a month.

Bleomycin
The wholesale cost in the developing world is between US$14 and US$78 a dose.

Bortezomib
In the United States it costs US$1,360 per 3.5 mg vial. In the United Kingdom this amount costs the NHS £762 such that a course of treatment is about £12,261 as of 2014.

Costs
In the UK, NICE initially recommended against Velcade in October 2006 due to its cost of about £18,000 per person, and because studies reviewed by NICE reported that it could only extend the life expectancy by an average of six months over standard treatment. However, the company later proposed a performance-linked cost reduction for multiple myeloma, and this was accepted.

Bremelanotide
In the United States it is sold for US$948 per dose as of 2019.

Brimonidine
One milliliter in the United Kingdom costs the NHS about 1.13 £ as of 2019. In the United States the wholesale cost of this amount is about US$0.60.

Budesonide
The wholesale price in the developing world for an inhaler containing 200 doses is about US$5 to US$7 as of 2014. As of 2015 the cost for a typical month of the inhaler medication in the United States is US$100 to US$200. In 2016 it was the 207th most prescribed medication in the United States with more than 2 million prescriptions.

Budesonide/formoterol
In the United States, as of 2017, the wholesale cost of an inhaler is about 30 USD. In the United Kingdom the cost as of 2015 was about 35 pounds for a unit with 120 doses.

Bumetanide
A month supply in the United Kingdom costs the NHS about 1.20 £ as of 2019. In the United States the wholesale cost of this amount is about US$12.

Bupivacaine
Bupivacaine is available as a generic medication and is not very expensive. The wholesale cost in the developing world of a vial is about US$2.10.

Cost
Bupivacaine is available as a generic medication and is not very expensive. The wholesale cost of a vial of bupivacaine is about US$2.10.

Buprenorphine
For the tablets the wholesale cost in the United States is between US$0.86 and US$1.32 per daily dose as of 2017.

Buprenorphine/naloxone
In the United States the wholesale cost as of 2017 is between US$2.32 and US$3.15 per day. In the United Kingdom a similar dose costs the NHS £0.90 to £2.72 per day, according to 2015 data.

Cost
In the United States the wholesale cost as of 2017 is between US$2.32 and US$3.15 per day. In the United Kingdom a similar dose costs the NHS £0.90 to £2.72 per day, according to 2015 data.

Bupropion
In the United States the wholesale cost per dose is less than US$0.50 as of 2018.

Buspirone
A month supply in the United Kingdom costs the NHS about 10 GBP as of 2019. In the United States the wholesale cost of this amount is about 2.65 USD.

Calamine
The wholesale cost in the developing world is about US$0.25–3.85 per 100-ml bottle. In the United Kingdom, it costs the National Health Service about £0.44.

Calcium gluconate
The wholesale cost in the developing world is about US$0.21–1.34 per one-gram vial, 10 ml of 100 mg/ml (10% solution). In the United Kingdom this amount costs the NHS about 0.65 pounds.

Calcium supplement
The wholesale cost in the developing world is about US$0.92–4.76 per month. In the United States treatment generally costs less than $25 per month.

Canagliflozin
A month's supply in the United Kingdom costs the NHS about £39.20 as of 2019. In the United States the wholesale cost of this amount is about US$475.20.

Canakinumab
One 150 mg subcutaneous injection, usually needed every two weeks, costs over $16,700; discounts are sometimes available.

Capecitabine
The wholesale cost in the developing world is about US$122.64–195.66 per cycle of medication. In the United Kingdom it costs the NHS about £210.67 per cycle. In the United States it costs about $1,892.00 as of 2016.

Capreomycin
The wholesale cost in the developing world is about 6.25 to 8.98 USD a dose.

Carbamazepine
The wholesale cost in the developing world is about US$0.07 to US$0.24 per day as of 2015.

Carbidopa/levodopa
The wholesale price in the developing world is about US$1.80 to $3.00 a month. In the United States, a month's supply costs about $50 to $150.

Cost
It is available as a generic medication and is moderately expensive. Globally, the wholesale price of the medication is about US$1.80 to $3.00 a month. In the United States a month's supply is about $50 to $150.

Carboplatin
The wholesale cost in the developing world is about US$26.49–37.37 per 450 mg vial. In the United Kingdom it costs the National Health Service (NHS) about 160 pounds (around US$200).

Carisoprodol
In the United States the wholesale cost is less than US$0.10 per dose.

Carvedilol
In the United States, the wholesale cost per dose is less than 0.05 USD as of 2018.

Cefalexin
Generic drug versions are available under other trade names and are inexpensive.

Cost
A seven day course of cephalexin costs a consumer about CA$25 in Canada in 2014. The wholesale cost of this amount is about CA$4.76 as of 2019. In the United States this amount costs a consumer about US$20.96 as of 2019. In Australia a course of treatment costs at most AU$26.77 as of 2019. The wholesale price in the developing world is about US$2.18 as of 2015.

Cefdinir
In the United States the wholesale cost of ten days of medication is about US$9.40.

Cefixime
The wholesale cost in the developing world is about US$0.26–2.09 per dose. In the United States a course of treatment costs about $100–200 as of 2015.

Cefotaxime
The wholesale cost in the developing world is about US$0.23–4.70 per dose. In the United States a course of treatment costs $100–200.

Ceftazidime
The wholesale cost in the developing world is about US$2.84–16.76 per day. In the United States a course of treatment costs $100–200.

Ceftriaxone
In the developed world the wholesale cost per dose is about US$0.20 to US$2.32 as of 2014. In the United States a course of treatment is typically less than US$25.

Cefuroxime
A week of treatment when taken by mouth in the United Kingdom costs the NHS about £18 as of 2019. In the United States, the wholesale cost of this amount is about US$8.50.

Celecoxib
A month supply in the United Kingdom costs the NHS less than £2 as of 2019. In the United States, the wholesale cost of this amount is about $US12.90.

Cost
, Zykadia is priced at US$8,578 per bottle of 70 capsules.

Cetirizine
A month's supply in the United Kingdom costs the NHS about £0.70 as of 2019. In the United States the wholesale cost of this amount is about US$2.50.

Chlorambucil
The wholesale cost in the developing world is about US$111.87 per month. In the United Kingdom it costs the NHS about £145.84 per month.

Chloramphenicol
The wholesale cost in the developing world of an intravenous dose is about US$0.40–1.90. In the United States an intravenous dose costs about $41.47.

Cost
In many areas of the world an intravenous dose is about US$0.40–1.90. In the United States it costs about $3.60 per dose in oral tablet form at wholesale. It is the cheapest treatment available for meningitis (US$5 per treatment course, compared to US$30 for ampicillin and US$15 for five days of ceftriaxone). It has the great advantage of requiring only a single injection, whereas ceftriaxone is traditionally given daily for five days. This recommendation may yet change, now that a single dose of ceftriaxone (cost US$3) has been shown to be equivalent to one dose of oily chloramphenicol.

Chlorhexidine
The wholesale cost in the developing world is about US$2.20–4.10 per liter of 5% solution. In the United Kingdom this amount costs the NHS about £4.80.

Chlorine-releasing compounds
The wholesale cost in the developing world is about US$0.01–0.02 per 500 mg of the chloramine type. They are used extensively in both the medical and the food industry.

Disinfectants
They are easy to use, widely available, and very cheap: as of 2014, the wholesale cost of chloramine-T in the developing world was US$0.01–0.02 per 500 mg tablet.

Chloroquine
The wholesale cost in the developing world is about US$0.04. In the United States, it costs about US$5.30 per dose.

Chloroxylenol
The wholesale cost in the developing world is about US$2.00–6.20 per litre of 5% solution.

Chlorpromazine
The wholesale cost in the developing world is between US$0.02 and US$0.12 per day. In the United States the wholesale costs is about US$7.80 per day as of 2019.

Chlortalidone
In the United States the wholesale cost is about US$13.50 a month.

Cost
In 2015, the wholesale cost in Costa Rica is about US$2.15 per 30 ml bottle of 10,000 IU/ml. In the United States, human treatment costs less than US$25 per month. In the UK, the cost to the NHS in 2018 for one month's treatment can be less than 3 GBP.

Ciclosporin
In 2016, the wholesale cost in the developing world was about US$106 a month. In the United Kingdom, it cost the NHS about £121 per month. The wholesale price in the United States was about US$173 per month.

Cilostazol
A month supply in the United Kingdom costs the NHS about 5 £ as of 2019. In the United States the wholesale cost of this amount is about US$6.20.

Ciprofloxacin
It is available as a generic medication and is not very expensive. The wholesale cost in the developing world is between US$0.03 and US$0.13 a dose. In the United States it is sold for about US$0.40 per dose.

Cost
It is available as a generic medication and not very expensive. Wholesale it costs between US$0.03 and US$0.13 a dose. In the United States it is sold for about US$0.40 per dose.

Cisplatin
The wholesale cost in the developing world is about US$5.56 to US$7.98 per 50 mg vial. In the United Kingdom this costs the NHS about £17.

Clarithromycin
The wholesale cost in the developing world is between US$0.13 and $0.79 per dose. In the United States it is moderately expensive at $50–100 for a course of treatment.

Cost
The wholesale cost is between US$0.13 and $0.79 per dose. In the United States it is moderately expensive at $50–100 for a course of treatment.

Clindamycin
It is available as a generic medication and is not very expensive. The wholesale cost in the developing world is about US$0.06–0.12 per pill. In the United States, it costs about $2.70 per dose.

Cost
It is available as a generic medication and is not very expensive. The wholesale cost in the developing world is about US$0.06 to US$0.12 per pill. In the United States it costs about $2.70 per dose.

Clobetasol propionate
A month supply in the United Kingdom costs the NHS about 7.90 £ as of 2019. In the United States the wholesale cost of this amount is about 66 USD.

Clofazimine
The wholesale cost in the developing world is about US$24 per month.

Clomifene
The wholesale cost in the developing world is about 0.79 to 2.00 USD for a course of treatment. In the United States the wholesale cost of a course of treatment is 4.80 USD.

Clomipramine
The wholesale price in the developing world is between 0.11 and 0.21 per day as of 2014. In the United States the wholesale costs as of 2018 is about US$9 per day.

Clonazepam
The wholesale cost in the developing world is between US$0.01 and US$0.07 per pill. In the United States, the pills are about US$0.40 each.

Clonidine
As of 2019 a month of medication costs the NHS about £8. In the United States this amount costs about US$2.70 as of 2019.

Clopidogrel
The wholesale cost in the developing world is about US$0.77–31.59 per month. In the United States, a month of treatment costs less than US$25.

Clotrimazole
The wholesale cost in the developing world as of 2014 is 0.20–0.86 USD per 20 gram tube of cream. In the United States a course of treatment typically costs less than US$25.

Society and culture
The wholesale cost in the developing world as of 2014 is 0.20–0.86 USD per 20gm tube of cream. In the United States treatment typically costs less than US$25.

Cloxacillin
The wholesale cost in the developing world is about US$0.16 per day for the pills.

Clozapine
The wholesale cost in the developing world is between US$0.05 and US$2.10 per day as of 2014.

Cost
The wholesale cost in the developing world is between 0.05 and US$2.10 per day as of 2014. In the United Kingdom the injectable form is about 100 pounds per dose.

Codeine
The wholesale cost in the developing world is between US$0.04 and US$0.29 per dose as of 2014. In the United States it costs about one dollar a dose.

Colchicine
It is available as a generic medication in the United Kingdom where a month's supply costs the NHS about £7.27, as of 2019. In the United States, the wholesale cost of this amount is about US$252.20.

History
URL Pharma raised the price from $0.09 per tablet to $4.85

Colistin
In the United Kingdom it costs the NHS about £5.40 per day for the injectable form as of 2018. In the United States this amount costs about US$47 as of 2019.

Condom
The wholesale cost in the developing world is about 0.03 to US$0.08 each. In the United States condoms usually cost less than US$1.00.

Copper IUDs
The wholesale cost in the developing world is about US$0.37–3.00 per IUD. In the United Kingdom they cost the NHS about £10 GBP. In the United States they cost around $750.

Cyanocobalamin
In the United Kingdom it costs the NHS about 2.90 £ per injection as of 2019. In the United States the wholesale cost of this amount was about US$0.77 in 2019.

Cyclobenzaprine
n the United States, the wholesale cost per dose is less than US$0.05 as of 2018.

Cyclophosphamide
The wholesale cost in the developing world is about US$3.65–14.30 per 1 g vial. In the United Kingdom this dose costs the NHS about 17.06 pounds. In the United States this dose by mouth is about $19.56.

Cycloserine
The wholesale cost in the developing world is about US$29.70–51.30 per month. In 2015, the cost in the United States was increased to US$3,150 a month and then decreased to US$1,050 per month.

Economics
In the U.S., the price of cycloserine increased from $500 for 30 pills to $10,800 in 2015 after the Chao Center for Industrial Pharmacy and Contract Manufacturing changed ownership to Rodelis Therapeutics in August 2015. The price increase was rescinded after the previous owner, the Purdue University Research Foundation, which retained "oversight of the manufacturing operation" intervened and Rodelis returned the drug to an NGO of Purdue University. The foundation now will charge $1,050 for 30 capsules, twice what it charged before".

Cytarabine
The wholesale cost in the developing world is about US$4.27 to US$5.70 per 500 mg vial. This dose in the United Kingdom costs the NHS about GB£50.00 while the liposomal form is GB£1,223.75 per 50 mg vial.

Dabigatran
A month supply in the United Kingdom costs the NHS about £51 as of 2019.

History
According to a BBC article in 2008, Dabigatran was expected to cost the NHS £4.20 per day, which was similar to several other anticoagulants.

Dacarbazine
The wholesale cost in the developing world is about US$7.45–18.24 per 200 mg vial. In the United Kingdom this dose costs the NHS about 7.50 pounds.

Dactinomycin
The wholesale cost in the developing world is about US$24.73 per 500 mcg vial.

Darunavir
The wholesale cost in the developing world is about US$66 per month. In the United States it costs more than $200 per month.

Daunorubicin
The wholesale cost in the developing world is about 5.79 to 37.18 USD for a 20 mg vial. This amount in the United Kingdom costs the NHS about 55.00 pounds.

Deferoxamine
The wholesale cost in the developing world is about US$6.76 to $13.52 per dose. In the United States a course of treatment costs more than $200.

Desiccated thyroid extract
In the United States the wholesale cost for a month of medication is about US$15.30.

Cost
Desonide topical cream and ointment is sold in 15g and 60g tubes of %0.05 gel, and desonide lotion is sold in 2 fluid ounce bottles. A single 60g tube or one (1) bottle of lotion costs as much as $200.

Desvenlafaxine
In the United States the wholesale cost is about 25.20 USD per month.

Dexlansoprazole
In the United States the wholesale cost for a month is about US$270. In Canada this amount costs about 71.50 CAD in 2016 making it the most expensive PPI available at the time.

Dexmethylphenidate
The wholesale cost of a month supply in the United States is about US$8.

Dextran 70
The wholesale cost in the developing world is about US$4.10–5.25 per 500 ml. In the United Kingdom this dose costs the NHS about 57.00 pounds. In the United States it costs about $25–50 per dose.

Diatrizoate
As of 2016, the wholesale cost in the developing world is about US$5.49 per 20 ml vial. In the United States a dose costs less than US$25.

Diazepam
The wholesale cost in the developing world is about US$0.01 per dose. In the United States, it is about US$0.40 per dose.

Diazoxide
In the United States as of 2019 it costs about US$1500 per month. In the United Kingdom this amount costs the NHS about £59.

Diclofenac
The wholesale cost in the developing world is generally less than US$2 per month as of 2015. In the United States the wholesale cost of this amount is typically less than US$9 as of 2018.

Cost
In the United States the NADAC per dose is less than US$0.15 as of 2018 for 50 mg and 75 mg tablets. The average wholesale cost in the United States in 2019 is about US$50 to $US100 per month at a typical dose.

Dicycloverine
In the United Kingdom the NHS pays about 1.84 £ per dose as of 2019. In the United States the wholesale cost of this amount is about 0.15 USD.

Diethylcarbamazine
The wholesale cost in the developing world is around one US penny per dose.

Digoxin
The wholesale cost in the developing world is about US$0.21 to $6.60 a month. In the United States it generally costs less than $25 per month, as of 2015.

Diltiazem
In the United States the wholesale cost per day of the by mouth formulation is less than 0.70 USD as of 2018.

Diphenhydramine
The wholesale price in the developing world is about US$.01 per dose. In the United States, it costs less than US$25 for a typical month’s supply.

Diphtheria vaccine
The wholesale price in the developing world of a version that contains tetanus toxoid is between 0.12 and 0.99 USD per dose as of 2014. In the United States it is less than 25 USD.

Docetaxel
The wholesale cost in the developing world is about US$15.53 to US$87.37 per 80 mg vial. This dose in the United Kingdom costs the NHS about £454.53.

Costs
In the UK (in 2009) The cost of six cycles (18 weeks) of docetaxel at a dose of 75 mg/m2 IV every 21 days is £5,262 (based on an average body surface area 1.75 m2).

Docosanol
When introduced in Canada in 2005 it sold for CA$6.12 per gram of 10% cream. In the United States in 2019 this amount cost US$10.36.

Donepezil
In the United Kingdom a typical months supply costs the NHS about £8.44 as of 2019. The wholesale cost of this amount in the United States is about US$1.38.

Dopamine (medication)
The wholesale cost in the developing world of a container of 400 mg is between $0.28 and $0.60 (USD) as of 2014.

Dorzolamide
A 5 milliliter bottle in the United Kingdom costs the NHS less than 2 £ as of 2019. In the United States the wholesale cost of this amount is about US$7.10.

Dorzolamide/timolol
A 5 milliliter bottle in the United Kingdom costs the NHS about 1.50 £ as of 2019. In the United States the wholesale cost of this amount is about US$8.30.

Cost
The brand name Cosopt currently costs upwards of $200 after discounts while the generic formulation costs around $70 cash. The more recent preservative free formulation can be purchased for less than the original brand name formulation at around $160

Doxazosin
A month supply in the United Kingdom costs the NHS about 0.50 £ as of 2019. In the United States the wholesale cost of this amount is about US$5.50.

Doxepin
A month supply in the United Kingdom costs the NHS at least 100 £ as of 2019. In the United States the wholesale cost of this amount is about US$23.

Doxorubicin
The wholesale cost in the developing world is about US$3.88–32.79 per 50 mg vial. In the United Kingdom this amount costs the NHS about £100.12.

Doxycycline
The wholesale cost in the developing world is between US$0.01 and US$0.04 per pill. In the United States, ten days of treatment has a wholesale costs of about US$3.40 as of 2019. However, in 2014, due to supply issues, it was being sold for as much as US$60.00–200.00 for that amount.

History
The market price for doxycycline dramatically increased in the United States in 2013 and early 2014 (from $20 to over $1800 for a bottle of 500 tablets),  before decreasing again.

Society and culture
Doxycycline is available as a generic medicine and is generally inexpensive. The wholesale cost is between US$0.01 and $0.04 per pill.

Duloxetine
In the United States the wholesale cost per dose is about US$0.20 as of 2018. In 2016 it was the 48th most prescribed medication in the United States with more than 15 million prescriptions.

Dutasteride
A month supply in the United Kingdom costs the NHS about £12 as of 2019. In the United States, the wholesale cost of this amount is about $6.66.

Efavirenz
The wholesale cost in the developing world is about US$3.27 to 9.15 per month. As of 2015 the cost for a typical month of medication in the United States is more than US$200.

Society and culture
A one-month supply of 600 mg tablets costs approximately US$1,010 in July 2016. In 2007, Merck provided Efavirenz in certain developing countries and countries largely affected by HIV for about US$0.65 per day. Some emerging countries have opted to purchase Indian generics. In Thailand, a one month supply of efavirenz + Truvada, as of June 2012, cost 2,900 baht (US$90), and there is a social program for patients who cannot afford the medication. Thailand will produce efavirenz domestically. Its Government Pharmaceutical Organization product costs 180 baht per bottle of thirty 600 mg tablets. The imported version in Thailand retails for more than 1,000 baht per bottle. GPO will devote 2.5 percent of its manufacturing capacity to make 42 million efavirenz pills in 2018, allowing it to serve export markets as well as domestic. The Philippines alone will order about 300,000 bottles of efavirenz for 51 million baht.

Efavirenz/emtricitabine/tenofovir
The wholesale cost in the developing world is about US$10.71–14.19 per month as of 2014. The wholesale cost in the United States is about $2308.20 a month as of 2016, while in the United Kingdom it costs the NHS GB£532.87 per month as of 2015.

History
An equivalent two pill regimen is available in developing countries at a price of about US$1.00 per day, as Gilead Sciences has licensed the patents covering emtricitabine/tenofovir to the Medicines Patent Pool and Merck and Co makes efavirenz available in developing countries at a reduced price.

Cost
The wholesale cost in the developing world is about US$10.71–14.19 per month as of 2014.

Empagliflozin
A month supply in the United Kingdom costs the NHS about £36.59 as of 2019. In the United States the wholesale cost of this amount is about US$442.

Emtricitabine/tenofovir
The 2015 wholesale cost in the developing world is about US$6.06 to US$7.44 per month. In the United States, as of 2019, the wholesale cost is about US$1,710.00 per month. In Australia, this amount costs about US$8.

Cost
, the median cost per tablet, in Namibia and South Africa, was US$0.20. In Canada, emtricitabine/tenofovir cost between $800 - $1,100 per month in 2016. Generic emtricitabine/tenofovir was approved by Health Canada in August 2017, with a wholesale cost of $400 per month. The cost for emtricitabine/tenofovir PrEP in Ontario, Canada dropped significantly after approval in September 2017. In the United States,, the wholesale cost is about US$1415.00 per month. This increased in 2019 to about US$1,710.00 per month. The price of emtricitabine/tenofovir in the United States has been criticized by activists, who argued in a 2018 The New York Times opinion piece that the high cost keeps the drug out of reach for millions, thus harming efforts to reduce new HIV infections. The Gilead CEO defended the high price at a U.S. House of Representatives committee hearing. Generic emtricitabine/tenofovir was approved in the United States in 2018, and it is scheduled to be released by Teva in September 2020.

Enalapril
The wholesale cost in the developing world is about US$0.08 to 0.80 per month. In the United States, it costs about $25 to $50 per month.

Enoxaparin sodium
The wholesale cost in the developing world is about US$1.90–10.80 per day. In the United States the wholesale cost is about $14.13 per day as of 2016.

Ephedrine
The wholesale cost in the developing world is about US$0.69–1.35 per dose. In the United States it is not very expensive.

Epinephrine (medication)
The wholesale cost in the developing world is between US$0.10 and US$0.95 a vial. In the United States, the cost of the most commonly used autoinjector for anaphylaxis was about US$600 for two in 2016, while a generic version was about US$140 for two. In Canada the wholesale cost of two cost is CA$190 as of 2019.

Cost
The wholesale cost of epinephrine in the developing world is between US$0.10 and US$0.95 a vial. In the United States, the cost of the most commonly used autoinjector for anaphylaxis was about US$600 for two in 2016, while a generic version was about US$140 for two. In Canada the wholesale cost of two cost is CA$190 as of 2019.

Ergometrine
The wholesale cost in the developing world is between US$0.12 and US$0.41 for an injectable dose and US$0.01 for a pill as of 2014. In the United States it is about US$1.75 per dose.

Erlotinib
In the United States,, it costs about US$8,832 per month. In the United Kingdom this amount costs the NHS about £1,631.53 per month.

Price
In the United States,, it costs about US$8,832 per month. In the United Kingdom this amount costs the NHS about £1,631.53 per month.

Erythromycin
It is available as a generic medication and is not very expensive. The wholesale price in the developing world is between 0.03 and 0.06 USD per tablet.

Cost
It is available as a generic medication and was inexpensive for many years. The wholesale price was between 0.03 and 0.06 USD per pill. In the United States in 2014 the price increased to seven dollars per tablet. The price of Erythromycin rose three times between 2010 and 2015, from 24 cents per tablet in 2010 to $8.96 in 2015. In 2017, a Kaiser Health News study found that the per-unit cost of dozens of generics doubled or even tripled from 2015 to 2016, increasing spending by the Medicaid program. Due to price increases by drug manufacturers, Medicaid paid on average $2,685,330 more for Erythromycin in 2016 compared to 2015 (not including rebates). By 2018, generic drug prices had climbed another 5% on average.

Erythropoiesis-stimulating agent
The wholesale cost of one version in the developing world, as of 2015, is about 3.80 USD per 2000 unit vial. In the United Kingdom this amount costs about 10 pounds as of 2015.

Escitalopram
In the United States the wholesale cost is about $2.04 per month. In the United Kingdom,, non-proprietary escitalopram is around 1 / 20th as costly as the proprietary version.

Esomeprazole
A month supply in the United Kingdom costs the NHS about £3 as of 2019. In the United States the wholesale cost of this amount is about 10 USD.

Eszopiclone
In the United States the wholesale cost is about 0.20 USD per dose.

Ethambutol
The wholesale cost in the developing world is about US$2.58–4.73 per month. In the United States it costs US$100–200 per month.

Ethambutol/isoniazid
The wholesale cost in the developing world is about 1.47 to 1.99 USD a month.

Ethambutol/isoniazid/rifampicin
The wholesale cost in the developing world is about 6.74 to 16.13 USD a month.

Ethinylestradiol/etonogestrel
In the United States the wholesale cost of this amount is about US$468.78.

Ethionamide
The wholesale cost in the developing world is about $5.94 to $24.12 USD per month.

Ethosuximide
The wholesale cost in the developing world is about US$27.77 per month as of 2014. In the United States the wholesale cost of this amount is about US$95.97 per month.

Etonogestrel birth control implant
The wholesale cost in the developing world is about 8.93 to 13.29 USD. In the United Kingdom the device costs the NHS about 83.43 pounds. The cost in the United States is about 625.00 USD.

Etoposide
The wholesale cost in the developing world is about US$3.24 to US$5.18 per 100 mg vial. In the United Kingdom this costs the NHS about £12.15 as of 2015.

Exenatide
A month supply in the United Kingdom costs the NHS about £82 for the daily injectable and £73 for the weekly injectable version as of 2019. In the United States the wholesale cost of this amount is about US$700 and US$789 respectively. In 2016 it was the 293rd most prescribed medication in the United States with more than a million prescriptions.

Ezetimibe
A month supply in the United Kingdom costs the NHS about £26.21 as of 2019. In the United States the wholesale cost of this amount is about US$5.85.

Cost
In the United States as of 2019 it costs about 0.21 USD per dose. In 2015, it cost between US$4.84 and 7.88.

Factor VIII (medication)
The wholesale cost in the developing world is about US$119–497 per 500 IU vial.

Famotidine
A month supply in the United Kingdom costs the NHS about 30 ₤ as of 2019. In the United States the wholesale cost of this amount is about 2 USD.

Febuxostat
In the United Kingdom a month of treatment costs the NHS about 24 pounds. In the United States the wholesale cost of a month's worth of medication is about US$320.

Fenofibrate
A month supply in the United Kingdom costs the NHS about 3.67 £ per month as of 2019. In the United States the wholesale cost of this amount is about US$8.40.

Fentanyl
For a 100 microgram vial, the average wholesale cost in the developing world was US$0.66 in 2015. In 2017, the price in the United States was US$0.49 for that same amount.

Cost
The wholesale cost in the developing world is between US$0.08 and US$0.81 per 100 microgram vial. In the United States this amount costs about US$0.40. In the United States the patches cost US$11.22 for a 12 µg/hr version and US$8.74 for a 100 µg/hr version.

Ferrous salt/folic acid
The wholesale cost in the developing world is about 0.07 to 1.02 USD a month. In the United Kingdom, it costs the NHS about 2.64 to 4.25 pounds per month.

Filgrastim
The wholesale cost in the developing world is about US$3.95 to US$94.66 per dose. In the United Kingdom it cost the NHS about £50.15 per 300 μg dose. In the United States treatment costs more than US$200. Filgrastim biosimilar medications are also available.

Finasteride
A month supply in the United Kingdom costs the NHS about £0.89 per month as of 2019. In the United States the wholesale cost of this amount is about US$2.34.

Flecainide
A month supply in the United Kingdom costs the NHS about £7.68 as of 2019. In the United States the wholesale cost of this amount is about 18.60 USD.

Fluconazole
The wholesale cost in the developing world is about US$0.05–0.10 per day. In the United States the wholesale price is about US$1.14–1.75 per day as of 2016.

Fludarabine
The wholesale cost in the developing world is about US$54.00 per 50 mg vial. In the United Kingdom it costs about 155.00 pounds per 50 mg vial.

Fluorescein (medical use)
The wholesale cost in the developing world is about US$12.25 per 5 ml bottle. In the United Kingdom a single dose costs the NHS about 0.43 pounds. It is also not very expensive in the United States.

Fluorouracil
The wholesale cost in the developing world is about US$1.18–3.40 per 500 mg vial. In the United Kingdom this amount costs the NHS about £6.40. In the United States it costs about $18.71.

Fluoxetine
The wholesale cost in the developing world is between US$0.01 and US$0.04 per day as of 2014. In the United States, it costs about US$0.85 per day. In 2016 it was the 29th most prescribed medication in the United States with more than 23 million prescriptions.

Fluphenazine
In the United States the tablets costs between $0.22 and $0.42 per day for a typical dose. The wholesale cost in the developing world of the long acting form is between US$0.20 and US$6.20 per injection as of 2014.

Availability
In the United States the tablets costs between 0.22 and 0.42 USD per day for a typical dose. The wholesale cost in the developing world of the long acting form is between 0.20 and 6.20 USD per injection as of 2014.

Fluticasone propionate
In the United States the wholesale cost per spray is about 0.33 USD as of 2018. In the United Kingdom, it costs the NHS about 0.13 GBP per spray as of 2019.

Fluticasone/salmeterol
A two month supply in the United Kingdom costs the National Health Service about £35 per month as of 2019. In the United States the wholesale cost of this amount is about 89 USD.

Folate
The wholesale cost of supplements in the developing world is between US$0.001 and 0.005 per dose as of 2014.

Fremanezumab
The wholesale cost in the United States as of 2019 is $US 369.90 per month.

Furosemide
In the United States, it is available as a generic medication and costs about US$0.15 per day.

Gabapentin
The wholesale price in the developing world was about US$10.80 per month; in the United States, it was US$100 to US$200.

Gemcitabine
The wholesale cost in the developing world is about US$24.41 to $316.99 per gram vial. In the United Kingdom a 1 g vial costs the NHS approximately £155.

Gemfibrozil
A month supply in the United Kingdom costs the NHS about 30 £ as of 2019. In the United States the wholesale cost of this amount is about 6 USD.

Gentamicin
The injectable's wholesale cost in the developing world in 2014 was between US$0.05 and US$0.58 per mL.

Glecaprevir/pibrentasvir
In the United States, a course of treatment costs about $27,600 as of 2019. This amount in the United Kingdom costs the NHS about £26,000 as of 2018.

Cost
In the United States, a course of treatment costs about $27,600 as of 2019. This amount in the United Kingdom costs the NHS about £26,000 as of 2018 while in Canada it is CA$40,000.

Glibenclamide
A month supply in the United Kingdom costs the NHS about £3.20 as of 2019. In the United States the wholesale cost of this amount is about $2.50.

Gliclazide
The wholesale cost in the developing world is about US$2.46–3.92 per month. In the United Kingdom a month of medication costs the NHS about 2.12 pounds.

Glimepiride
A month supply in the United Kingdom costs the NHS about 7.00 £ per month as of 2019. In the United States, the wholesale cost of this amount is about 2.15 USD.

Glipizide
In the United States the wholesale cost per dose is less than 0.05 USD as of 2018. In the United Kingdom it costs the NHS less than 0.05 pounds per dose as of 2018.

Glucagon (medication)
The wholesale cost in the developing world is about US$25.75 a dose. In the United Kingdom that dose costs the NHS about £11.52. In the United States the wholesale cost of a dose is US$247.32.

Glutaraldehyde
The wholesale cost in the developing world is about US$1.50–7.40 per liter of 2% solution.

History and culture
The wholesale cost in the developing world is about US$1.50–7.40 per liter of 2% solution.

Griseofulvin
The wholesale cost in the developing world is about US$0.05–0.18 per day. In the United States a course of treatment costs $100–200.

Guaifenesin
In the United States the wholesale cost is less than 0.10 USD per dose.

Guanfacine
A month supply in the United Kingdom costs the NHS about £60 as of 2019. In the United States the wholesale cost of this amount is about 7.11 USD.

HPV vaccine
The wholesale cost in the developing world is about US$47 a dose as of 2014. In the United States, it costs more than US$200.

<>

Halothane
As of 2014, the wholesale cost in the developing world is about 22 to 52 USD for a 250 mL bottle.

Society and culture
As of 2014, the wholesale cost in the developing world was 22 to 52 USD for a 250 mL bottle.

Hand sanitizer
The wholesale cost in the developing world is about US$1.40–3.70 per liter bottle.

Heparin
The wholesale cost in the developing world, when used for prevention, is about US$9.63–37.95 per month. In the United States it costs about $25–50 per month.

Hepatitis B vaccine
, the wholesale cost in the developing world is US$0.58–13.20 per dose. In the United States it costs US$50–100.
 * Costa Rica ||97

Hib vaccine
The wholesale cost of a pentavalent vaccine which includes Hib in the developing world was US$15.40 per dose as of 2014. In the United States it costs about $25–50 per dose.

Hormonal IUDs
The wholesale cost in the developing world is about US$122.46 each. In the United Kingdom they cost the NHS about £88. In the United States they cost around US$844.00,

Hydralazine
The wholesale cost in the developing world is about US$2.78–9.11 per month. In the United States treatment costs about $50–100 per month.

Hydrochlorothiazide/triamterene
A month supply in the United Kingdom costs the NHS about 0.95 £ per month as of 2019. In the United States the wholesale cost of this amount is about 3.90 USD.

Hydrocodone
In the United States the wholesale cost of the long-acting formulation is about 10 to 30 USD per dose as of 2019.

Hydrocortisone
The wholesale cost in the developing world is about US$0.27 per day as of 2014 for the form taken by mouth. In the United States, it costs less than US$25 for a typical month of treatment.

Hydromorphone
In the United Kingdom it costs the NHS about £0.32 per 2 mg tablet as of 2019. In the United States the wholesale cost of this amount is about US$0.07.

Hydroxocobalamin
The wholesale cost in the developing world is about US$0.12 to US$0.84 per dose (1 ml with 1 mg/ml concentration). In the United States the same amount costs about US$0.84 wholesale.

Hydroxycarbamide
The wholesale cost in the developing world is about US$0.35–0.47 per day. In the United States it costs less than $25 a month.

Hydroxychloroquine
The wholesale cost in the developing world is about $5.40 to 7.44 per month. In the United Kingdom this dose costs the NHS about £5.15. In the United States the wholesale cost of a month of treatment is about US$25 as of 2019.

Hydroxyzine
In the United Kingdom 28 doses cost less than a pound. In the United States the wholesale cost in 2018 was about 0.05 USD per dose.

Hyoscine butylbromide
The wholesale cost in the developing world is US$0.004–0.11 per pill as of 2014.

Ibuprofen
The wholesale cost in the developing world is between US$0.01 and US$0.04 per dose. In the United States, it costs about US$0.05 per dose.

Ifosfamide
The wholesale cost in the developing world is about US$7.35–70.70 per 2 gm vial. In the UK this dose costs the NHS about 130.04 pounds.

Imipenem/cilastatin
The wholesale cost in the developing world is about US$12.68 to $60 per day. In the United States it costs more than $200 for a course of treatment.

Influenza vaccine
The wholesale price in the developing world is about US$5.25 per dose. In the United States, the vaccine costs less than US$25 per dose,.

<>

Insulin (medication)
The wholesale cost in the developing world is about US$2.39 to $10.61 per 1,000 iu (34.7 mg) of regular insulin and $2.23 to $10.35 per 1,000 iu of NPH insulin. In the United Kingdom 1,000 iu of regular or NPH insulin costs the NHS £7.48, while this amount of insulin glargine costs £30.68.

<>

Insulin aspart
In the United Kingdom it costs the NHS about £1.89 per 100 units as of 2019. In the United States the wholesale cost of this amount is about US$30.00.

Insulin detemir
In the United Kingdom it costs the NHS about £2.80 per 100 units as of 2019. In the United States the wholesale cost of this amount is about US$29.50.

Insulin glargine
In the United States the wholesale cost per 100 units is about US$26 USD as of 2018. In the United Kingdom this amount costs the NHS about £2.35.

Insulin lispro
In the United Kingdom it costs the NHS about £1.89 per 100 units as of 2019. In the United States the wholesale cost of this amount is about US$30.00.

Cost
In the United States, in 2015, the cost was between $10.06 and $29.36 per 100 units. In April of 2019, Eli Lilly and Company announced they would produce a version selling for $137.35 per vial, about half the current cost. The chief executive said that this was a contribution "to fix the problem of high out-of-pocket costs for Americans living with chronic conditions", but Patients for Affordable Drugs Now said this was just a public relations move, as "other countries pay $20 for a vial of insulin.” The cost in the UK was between £1.66 (about $2.50) and £1.96 (about $3.00) per 100 units, in 2017.

Intravenous sodium bicarbonate
The wholesale cost in the developing world is about US$0.09–2.58 per 10 ml of 8.4% solution. In the United Kingdom this amount costs the NHS about 11.10 pounds.

Intravenous sugar solution
The wholesale cost in the developing world is about US$1.00–1.80 per liter of 10% dextrose in water, and it is about US$0.60–2.40 per liter of 5% dextrose in normal saline. In the United Kingdom a 50 ml vial of 50% solution costs the NHS 2.01 pounds.

Iohexol
The wholesale cost in the developing world is about US$10.99 per 50 ml vial. In the United States a dose costs US$50–100.

Ipratropium bromide
The wholesale price in the developing world is about 6.60 USD for a 200 dose inhaler. In the United States, a month worth of medication costs 100 to 200 USD.

Ipratropium bromide/salbutamol
Sixty doses in the United Kingdom costs the NHS about 18 £ as of 2019. In the United States the wholesale cost of this amount is about US$9.50.

Irbesartan
A month supply in the United Kingdom costs the NHS less than two pounds as of 2019. In the United States the wholesale cost of this amount is about six dollars.

Iron supplement
The wholesale cost in the developing world is about US$0.05–0.63 per month. In the United States a typical month of treatment costs less than $25.

Isoflurane
The wholesale cost in the developing world is about US$17.24–170.40 per 250 ml bottle.

Isoniazid
The wholesale cost in the developing world is about US$0.60–4.75 per month. In the United States a month of treatment costs less than $25.

Isoniazid/rifampicin
The wholesale cost in the developing world is about US$5.10 a month. In the United Kingdom a month of medication costs the NHS about 28.11 pounds.

Isosorbide dinitrate
The wholesale cost in the developing world is about US$6.36 a month. In the United States it costs less than US$25 per month.

Isosorbide mononitrate
A month supply in the United Kingdom costs the NHS about one £ per month as of 2019. In the United States the wholesale cost of this amount is about US$4.30.

Itraconazole
The wholesale cost in the developing world is about 0.29 USD per day of treatment. In the United States,, the wholesale cost of this dose is 6.36 USD.

Ivermectin
The wholesale cost in the developing world for the tablets is about US$0.12 for a course of treatment. In the United States, the costs is less than US$50.

Ivermectin is more effective than albendazole and equally as effective as thiabendazole for treatment of threadworm (strongyloidiasis). Ivermectin has fewer adverse effects than does thiabendazole and is at least as well tolerated as albendazole. An analysis based on an economic model suggests that it is cost effective for people moving to Europe from areas where threadworm is common to be given a single-dose of ivermectin on arrival so as to cure presumptive infection with threadworm. Persons who are immunocompromised or who will receive immunosuppressive treatment and who have confirmed or presumptive threadworm infestation are likely to benefit from treatment with ivermectin.

Cost
The wholesale cost in the developing world is about US$0.12 for a course of treatment as of 2014. This is down from an initial cost of US$6 proposed by Merck in 1987.

In the United States a course of treatment with pills costs about US$25–50 for a typical adult. As of 2019 ivermectin tablets were the least expensive treatment option for lice in children at about US$10. The hair lotion, however, is about US$300 for a course of treatment.

Kanamycin A
The wholesale cost in the developing world is US$0.85–1.52 per dose as of 2014.

Ketamine
The wholesale price in the developing world is between US$0.84 and US$3.22 per vial.

Ketoconazole
A 30-gram tube in the United Kingdom costs the NHS less than £5 as of 2019. In the United States, where the topical cream is available only by prescription, the wholesale cost of this amount is about US$6.30.

Ketorolac
In the United Kingdom it costs the NHS less than £1 per injectable dose as of 2019. In the United States the wholesale cost of this amount is about US$1.50.

Labetalol
A month supply in the United Kingdom costs the NHS about 8 £ as of 2019. In the United States the wholesale cost of this amount is about US$12.

Lactulose
In various countries it could be purchased for about US$0.16 per 15 ml of syrup (10 g of lactulose) in 2015. In the United States, the cost of this amount is about US$0.63.

Cost
The wholesale price is about US$0.18 per 15-ml dose. In the United States, 30 doses of the liquid cost about $20.

Lamivudine
The wholesale cost in the developing world as of 2014 is about US$0.06 per day. As of 2015 the cost for a typical month of medication in the United States is more than $200.

History
As of 2015 the cost for a typical month of medication in the United States is more than $200.

Lamivudine/nevirapine/stavudine
The wholesale cost in the developing world is about 9.56 USD per month.

Lamivudine/nevirapine/zidovudine
The wholesale cost in the developing world is about 8.54 to 18.94 USD a month as of 2014.

Lamivudine/zidovudine
The wholesale cost in the developing world is about US$6.90 to $29.64 per month. As of 2015 the cost for a typical month of medication in the United States more than $200.

Society and culture

 * 1) Combivir: lamivudine 150 mg and zidovudine 300 mg (scored). 60 tablets cost $994.

Lamotrigine
The wholesale cost in the developing world is about US$3.50 to US$23 per month as of 2015. In the United States, this amount has a wholesale cost of about US$4.60 as of 2019.

Lansoprazole
A one month supply, in the United Kingdom, costs the NHS less than £5,. In the United States, the wholesale cost of this amount is about $5.40, as of 2019.

Latanoprost
The wholesale cost in the developing world is about US$0.69–3.79 per 2.5 ml bottle. In the United States a month of treatment costs less than $25.

Lenalidomide
In the United States it costs about US$16,000 to US$21,000 per month as of 2019. In the United Kingdom this amount costs the NHS about £3,400 to 4,400.

Price
Lenalidomide costs $163,381 per year for the average person in the United States.

Levamisole
The wholesale cost in the developing world is about US$0.18 to US$0.33 for a course of treatment.

Levetiracetam
A month supply in the United Kingdom costs the NHS about £19.31 per month as of 2019. In the United States the wholesale cost of this amount is about US$4.50.

Levocetirizine
A month supply in the United Kingdom costs the NHS about 4.50 £ as of 2019. In the United States the wholesale cost of this amount is about US$3.

Levofloxacin
The wholesale cost in the developing world is about US$0.44–0.95 per week of treatment. In the United States a week of treatment costs about $50–100.

Levonorgestrel
The wholesale cost in the developing world is between $0.23 and $1.65 US for the dose required for emergency birth control.

Levonorgestrel-releasing implant
The wholesale cost in the developing world is about US$8.93–13.29 per set.

Levothyroxine
The wholesale cost in the developing world is about US$0.58 to US$12.28 per month. In the United States, a typical month of treatment costs less than US$25.

Lidocaine
It is available as a generic medication and is not very expensive. The wholesale cost in the developing world in 2014 was US$0.45 to $1.05 wholesale per 20 ml vial of medication.

Linagliptin
A month supply in the United Kingdom costs the NHS about £33.26 as of 2019. In the United States the wholesale cost of this amount is about 391 USD.

Liothyronine
A month's supply in the United Kingdom costs the NHS about GB£247 as of 2019. In the United States the wholesale cost of this amount is about US$22.40.

Pricing
The British Competition and Markets Authority launched an investigation into the alleged "excessive and unfair pricing" of liothyronine tablets in 2017. It alleged that Advanz Pharma overcharged the NHS from before 2007 to July 2017. The price of a pack increased by almost 1,600% from £4.46 before it was debranded in 2007 to £258.19 by July 2017.

Liraglutide
A month supply in the United Kingdom costs the NHS about £78.50 as of 2019. In the United States the wholesale cost of this amount is about US$98.30.

Lisdexamfetamine
A month supply in the United Kingdom costs the British National Health Service about 58.00 POUND In the United States, the wholesale cost of this amount is about US$264.

Lisinopril
In the United States the wholesale cost per month was less than 0.70 USD as of 2018. In the United Kingdom it cost the NHS about 10 pounds per month as of 2018.

Lisinopril/hydrochlorothiazide
In the United States the wholesale cost per dose is less than US$0.05. In the United Kingdom it costs the NHS about 0.40 pounds per dose.

Lithium (medication)
The wholesale cost in the developing world in 2014 was between 0.12 and 0.20 USD per day. In the United States at usual doses it costs about 0.90 to 1.20 USD per day.

Loperamide
Loperamide is available as an inexpensive generic medication. The wholesale cost in the developing world is about US$0.004 to 0.040 per dose. In August 2016, the US retail cost is about US$0.31 per dose.

Cost
It is sold as a generic medication and is not very expensive. The wholesale cost in the developing world is about US$0.004 to 0.040 a dose. In August 2016, the US retail cost is about $0.31 per dose.

Lopinavir/ritonavir
The wholesale cost in the developing world is 18.96 to 113.52 a month. In the United States it is not available as a generic medication and costs more than US$200 for a typical month supply as of 2016.

Loratadine
The wholesale cost in the developing world is about US$0.01 to 0.06 per dose as of 2015.

Lorazepam
The wholesale cost in the developing world of 1 mg dose by mouth is about US$0.02 to US$0.21 as of 2015. This amount in the United Kingdom costs the NHS about £0.14. In the United States as of 2015 a typical month's supply is less than US$25.

Losartan
The wholesale cost in the developing world is about US$0.28–3.45 per month as of 2015. In the United States, as of 2017, the wholesale cost of a typical dose is $1.13 per month.

Losartan/hydrochlorothiazide
A month supply in the United Kingdom costs the NHS about 1.50 £ per month as of 2019. In the United States the wholesale cost of this amount is about US$2.50.

Lovastatin
In the United States the wholesale cost is about 0.05 USD per dose.

Lurasidone
A month supply in the United Kingdom costs the NHS about £90.72 as of 2019. In the United States the wholesale cost of this amount is about US$190.20.

Macrogol
In the United Kingdom it costs the NHS about £0.14 per dose as of 2019. In the United States the wholesale cost of this amount is about US$1.40.

Magnesium sulfate (medical use)
The wholesale cost in the developing world is about US$0.35–8.73 per 10 ml of 50% solution. In the United Kingdom 4 ml of 20% solution costs the NHS about 10.23 pounds. In the United States a course of medication typically costs less than $25.

Mannitol
The wholesale cost in the developing world is about 1.12 to US$5.80 per dose. In the United States, a course of treatment costs $25 to $50.

Measles vaccine
The wholesale cost in the developing world is about 0.70 USD per dose as of 2014.

Mebendazole
The wholesale cost in the developing world is between USD 0.004 and 0.04 per dose. In the United States a single dose is about USD 440.00 as of 2016, while in Australia and the UK it costs about USD 5.00.

Cost
In the developing world the wholesale cost is between USD 0.004 and 0.04 per dose as of 2014. In the United States a single dose was about USD 18.00 in 2015. In 2016 the price increased to USD 440.00 per dose in the U.S. as Amedra Pharmaceuticals acquired the rights from Teva in 2013.

Meclizine
In the United States the wholesale cost per dose is about US$0.03.

Medroxyprogesterone acetate
The wholesale cost in the developing world is about US$0.59–1.57 per vial. In the United Kingdom this dose costs the NHS about 6.01 pounds. In the United States it costs less than $25 a dose as of 2015.

Mefloquine
The wholesale price in the developing world is about US$0.6–1.3 per dose. In the United Kingdom it costs the NHS £1.82 per dose. In the United States it costs about $10 a dose.

Meglumine antimoniate
The wholesale cost in the developing world is about 4.32 USD per vial as of 2014.

Meloxicam
In the United States the wholesale cost per dose is less than US$0.02. In the United Kingdom it costs about 0.13 pounds.

Melphalan
In the United Kingdom it costs the NHS £137 per 50 mg vial. In the United States the cost of this amount is US$257.

Memantine
A month supply in the United Kingdom costs the NHS about 1.60 GBP as of 2019. In the United States the wholesale cost of this amount is about US$5.50.

History
The cost of Namenda was $269 to $489 a month in 2012.

Meningococcal vaccine
The wholesale cost in the developing world is between US $3.23 and $10.77 per dose as of 2014. In the United States it costs $100–200 for a course.

Mercaptopurine
The wholesale cost in the developing world is about US$18.42–200.16 a month. In the United Kingdom this costs the NHS about 121.13 pounds per month. In the United States the wholesale cost is about $99.16 per month as of 2016.

Meropenem
The wholesale cost in the developing world is between 3.44 and 20.58 USD per one gram vial as of 2015. In the United Kingdom this amount costs the NHS about £16 in 2015.

Meropenem/vaborbactam
In the United States it costs about US$1,126 per day as of 2019.

Mesalazine
A month supply in the United Kingdom costs the NHS about £43 as of 2019. In the United States the wholesale cost of this amount is about 288 USD.

Mesna
The wholesale cost in the developing world is about US$3.50 per 400 mg vial. In the United Kingdom this amount costs the NHS about £3.95.

Metformin
The wholesale price in the developed world was between US$0.21 and $5.55 per month as of 2014. In the United States, it costs US$5 to US$25 per month.

Methocarbamol
A month supply in the UK costs the NHS about £12.72 as of 2019. In the US the wholesale cost of this quantity is about US$6.50.

Methotrexate
The wholesale cost as of 2014 in the developing world is between US$0.06 and US$0.36 per day for the form taken by mouth. In the United States, a typical month of treatment costs $25 to $50.

Methyldopa
The wholesale cost in the developing world is about US$4.31–9.48 per month. In the United States it costs less than $25 per month.

Methylene blue
In the United States, a 50 mg vial costs about 191.40 USD. In the United Kingdom, a 50 mg vial costs the NHS about £39.38.

Methylphenidate
In the United States, the wholesale cost of the immediate release formulation is less than US$0.30 per dose as of 2018.

Cost
Generic immediate-release methylphenidate is relatively inexpensive. The average wholesale cost is about US$0.15 per defined daily dose (retail pharmacies normally charge more). However, the most expensive brand-name extended-release tablets may retail for as much as $12.40 per defined daily dose.

Methylprednisolone
The wholesale cost in the developing world is about US$3.81–9.35 per 500 mg vial. In the United States, a course of treatment typically costs less than $25.

Metoclopramide
The wholesale cost in the developing world as of 2014 is US$0.003 to US$0.08 per pill. In the United States a month worth of medication is generally less than US$25.

Miconazole
The wholesale cost in the developing world is about 0.23 to US$0.60 for a 30 gram tube. In the United States a course of treatment costs less than US$25.

Midazolam
Midazolam is available as a generic medication and is not very expensive. The wholesale cost in the developing world of a vial is about US$0.35.

Cost
Midazolam is available as a generic medication and is not very expensive. The wholesale price of a vial is about US$0.35.

Minocycline
A month supply in the United Kingdom costs the NHS about 14 £ as of 2019. In the United States the wholesale cost of this amount is about US$12.

Cost
A month supply in the United Kingdom costs the NHS about 14 £ as of 2019. In the United States the wholesale cost of this amount is about US$12. In October 2015, a bottle of 30 of tablets of one brand cost $1,040.41 wholesale. Expensive medications like this were sold through the specialty pharmacy Philidor by Valeant Pharmaceuticals International Inc in a 2015 controversial legal tangle involving both companies.

Mirabegron
A month supply in the United Kingdom costs the NHS about £29 as of 2019. In the United States the wholesale cost of this amount is about 369 USD.

Mirtazapine
In the United States the wholesale cost as of 2018 is about US$3 per month. In the United Kingdom a month supply costs less than £20 per month.

Misoprostol
The wholesale cost in the developing world is about 0.36 to 2.00 USD a dose. A month's supply to treat stomach ulcers in the United States is between 100 and 200 USD. The same costs between 30 and 55 EUR in Europe.

Modafinil
In the United Kingdom it costs the NHS about £105.21 a month as of 2018. In the United States the wholesale cost per month is about US$34.20 as of 2018.

Mometasone/formoterol
In the United States the wholesale cost of a puffer is about 202 USD as of 2019.

Monochloramine
The wholesale cost in the developing world is about US$13.80 to US$18.41 per 500 grams.

Montelukast
In the United States, the wholesale cost per dose is less than 0.15 USD as of 2018. In the United Kingdom, it costs the NHS about a pound per dose. In 2016, it was the 23rd most prescribed medication in the United States, with more than 25 million prescriptions.

Moxifloxacin
The wholesale cost in the developing world is US$0.45–2.70 per day, as of 2015. In the United States, as of 2017, the wholesale cost is about $4.00 per day.

Mumps vaccine
The wholesale cost in the developing world of the version that includes measles and rubella is 0.24 USD per dose as of 2014.

Mupirocin
The wholesale cost in the developing world is about US$2.10 for a 15 g tube. In the United States, a course of treatment costs $25 to $50.

Mycophenolic acid
In the United Kingdom it costs the NHS about £14 per month. In the United States this amount is about US$114.

NPH insulin
The wholesale cost in the developing world is about US$2.23–10.35 per 1,000 iu of NPH insulin. In the United Kingdom 1,000 iu of NPH insulin costs the NHS £7.48 while in the United States this amount costs about US$134.00.

Nadolol
A month supply in the United Kingdom costs the NHS about £6 as of 2019. In the United States the wholesale cost of this amount is about $US 52.

Naloxone
Its wholesale price in developing countries is between $0.50 and $5.30 per dose. Vials of naloxone are not very expensive (less than $25) in the United States. However, the price for a package of two auto-injectors in the US has increased from $690 in 2014 to $4,500 in 2016. The 2018 price for the NHS in the United Kingdom is about £5 per dose. In Australia, a single dose without prescription costs AU$20 while with a prescription five doses is AU$40.

Naltrexone
As of 2019, the wholesale cost of tablets is about US$0.78 per day in the United States. The extended-release injections cost about $1,267 per month ($41.20 per day).

Naproxen
In the United Kingdom, it cost about £0.15 per dose in 2017. In the United States, the wholesale cost per dose is less than US$0.10 as of 2018.

Natamycin
The wholesale cost in the developing world is between US$92.90 and 126.72 per 5-ml bottle as of 2015.

Nebivolol
A month supply in the United Kingdom costs the NHS about 0.89 £ as of 2019. In the United States the wholesale cost of this amount is about US$128.00.

Neomycin/polymyxin B/hydrocortisone
In the United Kingdom a 10 ml bottle costs the NHS about £7.45 as of 2019. In the United States the wholesale cost of this amount is about 50 USD.

Cost
In David Lazarus' February 4, 2016 LA Times column, a pharmacist recalled a 10 milliliter vial of the drug selling for around $10 in the early 2010s. In 2015, the price was $100, and in 2016, it reportedly was selling for $195. A generic version is priced at $144.

Neostigmine
The wholesale cost in the developing world is about US$0.18–2.6 per dose.

Cost
The average yearly cost for a Medicare Part D patient for Ilevro is $94. The estimated per unit price in the United States for Nevanac is $88.93. For Ilevro, the per unit price for the 1.7 mL bottle averages $156.89 and the per unit price for the 3 mL bottle averages $88.91. Average price for both drugs is similar.

Nevirapine
The wholesale cost in the developing world is US$2.16 to $16.62 per month as of 2014. As of 2015, the cost for a typical month of medication in the United States was more than $200.

Niclosamide
The wholesale cost in the developing world is about 0.24 USD for a course of treatment.

Nifedipine
The wholesale price in the developing world for the slow-release form is approximately US$1.90–3.80 per month. In the United States, it costs approximately $40–60 per month, depending on the dose. {{cite web|title=Nifedipine|url=https://www.drugs.com/monograph/nifedipine.html|publisher=The American Society of Health-System Pharmacists|accessdate=Sep 17, 2019

Nilotinib
In the United Kingdom it costs the NHS £2,432.85 per month as of 2018. In the United States this amount costs US$14,367.94 as of 2019. In the United Kingdom it costs the NHS £2,432.85 per month as of 2018. In the United States this amount costs US$14,367.94 as of 2019.

Nitrofurantoin
The wholesale cost in the developing world is between 0.10 and 9.20 USD for a course of treatment. In the United States, the wholesale cost is about 8 USD for this amount as of 2018.

Cost
The wholesale cost in the developing world is between 0.10 and 9.20 USD for a course of treatment. In the United States, the wholesale cost is about 8 USD for this amount as of 2018. The cost of the liquid formulation of nitrofurantoin in the U.S. became controversial after a 400% price increase. There are two manufacturers of the liquid formulation in the U.S., Casper Pharma and Nostrum Laboratories. In 2018, Casper increased their price to $2,800. In response to Casper, Nostrum increased their price from $474.75 to $2,392. In the U.K., a slightly larger bottle costs £446.95. In an interview with the Financial Times, Nirmal Mulye, Nostrum chief executive, said that there was a "moral requirement to sell the product at the highest price." He defended Martin Shkreli, and said, "This is a capitalist economy and if you can’t make money you can’t stay in business." Mulye also attacked the U.S. Food and Drug Administration as "incompetent and corrupt." There is a shortage of liquid nitrofurantoin, because the FDA implemented new rules on impurities, he said. Mulye dismissed the new rules on impurities as a "piece of nonsense." FDA commissioner Scott Gottlieb tweeted a response: "[T]here’s no moral imperative to price gouge and take advantage of patients. FDA will continue to promote competition so speculators and those with no regard to public health consequences can’t take advantage of patients who need medicine."

Nitroglycerin (medication)
The wholesale cost in the developing world as of 2014, was US$0.06–0.22 per dose by mouth.

Nivolumab
In the United Kingdom it costs the NHS about £5266 a month as of 2018. In the United States this amount costs about US$13,556 as of 2019, while in China it is about US$7,000.

Norepinephrine (medication)
The wholesale cost in the developing world as of 2015 is about 0.42 USD per vial of four milligrams. In the United Kingdom this amount costs the NHS about 4.40 pounds.

Norethisterone enanthate
The wholesale cost in the developing world is about US$1.04–7.99 per 200 mg vial.

Nortriptyline
Nortriptyline was approved for medical use in the United States in 1964. A month supply in the United Kingdom costs the NHS about £25.00 as of 2019. In the United States the wholesale cost of this amount is about US$4.20.

Nystatin
The wholesale price of the cream in the developing world is about US$0.70 per 30 gram tube. In the United States a course of treatment costs less than US$25.

Ofloxacin
The wholesale cost in the developing world is about US$3.27 per month. In the United States, a course of treatment costs about $50–100.

Olanzapine
In the United States, the wholesale cost is less than US$0.25 per dose as of 2018.

Olmesartan
A month supply in the United Kingdom costs the NHS less than 2.50 £ as of 2019. In the United States the wholesale cost of this amount is less than US$5.

Olmesartan/hydrochlorothiazide
A month supply in the United Kingdom costs the NHS about 13 £ as of 2019. In the United States the wholesale cost of this amount is about US$6.

Olopatadine
A 5 milliliter bottle of the eye drops in the United Kingdom costs the NHS less than £5 as of 2019. In the United States the wholesale cost of this amount is about US$12.50.

Omega-3 acid ethyl esters
A one-month supply in the United Kingdom costs the NHS about £6 as of 2019. In the United States the wholesale cost of this amount is about 7.50 USD.

Omeprazole
The wholesale cost in the developing world as of 2014 is US$0.01 to US$0.07 per dose. In the United States, it costs on average US$0.50 per pill.

Ondansetron
The wholesale cost of the injectable form in the developing world is about US$0.10 to US$0.76 per dose. In the United States it costs about US$1.37 per tablet.

Oral rehydration therapy
The wholesale cost in the developing world of a package to mix with a liter of water is US$0.03 to 0.20.

Oseltamivir
the wholesale cost in the developing world was about US$4.27 per day. The wholesale cost for a course of treatment in the United States is about US$54.00 as of 2019.

Oxaliplatin
The wholesale cost in the developing world is 8.74 to 125.43 USD a vial. In the United Kingdom it costs the NHS 299.50 pounds per 100 mg dose.

Oxcarbazepine
A month supply in the United Kingdom costs the NHS about 6.50 £ as of 2019. In the United States the wholesale cost of this amount is about US$7.15.

Oxybutynin
A month supply in the United Kingdom costs the NHS less than GB£3 per month as of 2019. In the United States the wholesale cost of this amount is about US$14.

Oxycodone
In the United States, the wholesale cost per dose is less than US$0.30 as of 2018.

Oxytocin (medication)
, the wholesale cost in the developing world is US$0.10 to 0.56 per dose.

Paclitaxel
The wholesale cost in the developing world is about US$7.06–13.48 per 100 mg vial. This amount in the United Kingdom costs the NHS about 66.85 GBP.

Cost
, the cost to the NHS per patient in early breast cancer, assuming four cycles of treatment, was about £4000 (approx. $6000).

Pancreatic enzymes (medication)
In the United Kingdom a typical month's supply costs the NHS about £12.93 to £47.55 as of 2019. In the United States the wholesale cost of this amount is about US$300 to US$900.

Pantoprazole
As of 2018, the wholesale cost of the pills in the United States is less than US$0.10 per dose. In the United Kingdom, this amount costs less than 0.05 pounds, while the intravenous formulation costs about 5 pounds per dose.

Paracetamol
The wholesale price in the developing world is less than US$0.01 per dose. In the United States, it costs about US$0.04 per dose.

Cost
The wholesale price in the developing world is less than US$0.01 per dose. In the United States, it costs about US$0.04 per dose. In Europe, prices differ from country to country; low-cost prices for 10 doses could reach €0.54 in Portugal, €0.91 in France and €1.97 in Germany.

Paroxetine
A month supply in the United Kingdom costs the NHS about £1.10 per month as of 2019. In the United States the wholesale cost of this amount is about US$2.40.

Society and culture
A month supply in the United Kingdom costs the NHS about 1.10 £ per month as of 2019. In the United States the wholesale cost of this amount is about US$2.40.

Pegaspargase
In the United States it costs about $US17,800 per 3750 units vial.

Penicillamine
The wholesale cost in the developing world is about US$0.55 to $1.20 a dose. A month supply in the United Kingdom costs the NHS about 178 £ as of 2019. In the United States the costs of the medication increased from about 500 USD to 24,000 USD per month in 2016.

Society and culture
In November 2010, the public-private consortium GAVI announced that the cost of the pentavalent vaccine for emerging-market countries had dropped below $3.00 USD per dose. In contrast, a typical wholesale cost of a DTPw-HepB-Hib pentavalent vaccine was about $15.40 USD in 2014.

Peritoneal dialysis
The cost of dialysis solution in the developing world is about US$6.77–7.30 per two-liter bag or about $12,000 per year. In the United States peritoneal dialysis costs the government about $53,400 per person per year.

Permethrin
The wholesale cost in the developing world is about US$0.02 to US$0.06 per gram. In the United States, a course of treatment costs US$25 to US$50, and it is available over the counter.

Pertussis vaccine
A version that also includes tetanus, diphtheria, polio, and Hib vaccine is available wholesale in the developing world at a cost of 15.41 USD per dose as of 2014.

Phenoxymethylpenicillin
The wholesale cost in the developing world is about US$0.05–0.96 per day. In the United States a course of treatment costs less than $25.

Phentermine
The wholesale cost of a month supply in the United States is about US$2.55.

Phenytoin
Phenytoin is available as a generic medication and usually not too expensive. The wholesale cost in the developing world is between US$0.003 and US$0.15 per dose. A month of treatment is about US$30 in the United States.

Cost
Phenytoin is available as a generic medication and usually not too expensive. Wholesale it costs between US$0.003 and US$0.15 per dose. A month of treatment is about US$30 in the United States. After Pfizer's sale of the UK marketing licence to Flynn Pharma, the price of a 28-pack of 25 mg phenytoin sodium capsules marked Epanutin rose from 66p (about $0.88) to £15.74 (about $25.06). Capsules of other strengths also went up in price by the same factor—2384%, costing the UK's National Health Service an extra £43 million (about $68.44 million) a year. The companies were referred to the Competition and Markets Authority who found that they had exploited their dominant position in the market to charge "excessive and unfair" prices. The Competition and Markets Authority (CMA) imposed a record £84.2 million fine on the manufacturer Pfizer, and a £5.2 million fine on the distributor Flynn Pharma and ordered the companies to reduce their prices.

Phytomenadione
The wholesale cost in the developing world is about 0.11 to 1.27 USD for a 10 mg vial. In the United States a course of treatment costs less than 25 USD.

Pilocarpine
The wholesale cost in the developing world is about US$1.61–4.88 per 10 ml bottle. In the United States a month of the drops costs less than $25 as of 2015. It is one of the lowest cost medications for glaucoma.

Cost
The wholesale cost in the developing world is about US$1.61–4.88 per 10 ml bottle. In the United States a month of the drops costs less than $25. It is one of the lowest cost medications for glaucoma.

Pioglitazone
A month supply in the United Kingdom costs the NHS less than £1 as of 2019. In the United States the wholesale cost of this amount is about 3.20 USD.

Piperacillin/tazobactam
The wholesale cost in the developing world, as of 2015, is about US$11 per day. In the United Kingdom, as of 2015, this amount costs the NHS about 38.70 pounds per day.

Plazomicin
The price of 10 days of treatment in the United States costs about US$6,600.

Pneumococcal vaccine
The wholesale cost in the developing world is about US$17 per dose as of 2014. In the United States it is between US$25 and US$100.

Polio vaccine
The wholesale cost in the developing world is about US$0.25 per dose for the oral form as of 2014. In the United States, it costs between $25 and $50 for the inactivated form.

Cost
The wholesale cost is about US$0.25 per dose for the oral form as of 2014. The Global Alliance for Vaccines and Immunization supplies the inactivated vaccine to developing countries for as little as €0.75 (about US$) per dose in 10-dose vials. In the United States, the inactivated form costs between $25 and $50.

Polymyxin B
In the United States it costs about US$17 per day.

Polystyrene sulfonate
A single dose in the United States costs about $US13.50 while 30 doses cost about $US64.00 as of 2019.

Potassium chloride (medical use)
The wholesale cost in the developing world is about 0.44 USD per 10 ml of 10% solution. In the United Kingdom 10 ml of 15% solution costs the NHS about 0.48 pounds.

Potassium permanganate
The wholesale cost in the developing world is about US$0.01 per gram of powder.

Potassium permanganate (medical use)
The wholesale cost in the developing world is about 0.01 USD per g. In the United Kingdom this amount costs the NHS about £1.33.

Povidone-iodine
The wholesale cost in the developing world is about US$3.30 to US$11.40 per liter of 10% solution. This amount in the United Kingdom cost the NHS about £10.86.

Pramipexole
A month supply in the United Kingdom costs the NHS about £8.40 as of 2019. In the United States the wholesale cost of this amount is about 5 USD.

Pravastatin
In the United States the wholesale cost per dose is less than 0.20 USD as of 2018. In the United Kingdom it costs the NHS about a pound per dose.

Praziquantel
The wholesale cost in the developing world is about US$0.4–18.15 per day. In the United States a typical course of treatment costs $100–200.

Prazosin
A month supply in the United Kingdom costs about £3.50 as of 2019. In the United States, the wholesale cost of this amount is about US$20.

Prednisone
In the United States, the wholesale cost per dose was less than US$0.30 in 2018.

Pregabalin
In the US the wholesale costs is about US$11 per month as of October 2019. While in the United Kingdom a similar dose costs the NHS about £6 as of 2018.

Cost
In the United States as of July 2019 the cost for generic pregabalin is US$0.17-0.22 per 150 mg capsule. Pfizer's main patent for Lyrica, for seizure disorders, in the UK expired in 2013. In November 2018 the Supreme Court of the United Kingdom ruled that Pfizer's second patent on the drug, for treatment of pain, was invalid because there was a lack of evidence for the conditions it covered – central and peripheral neuropathic pain. From October 2015 GPs were forced to change people from generic pregabalin to branded until the second patent ran out in July 2017. This cost the NHS £502 million.

Primaquine
The wholesale cost in the developing world is US$0.04–0.11 per day.

Primidone
A month supply in the United Kingdom costs the NHS about 68.40 £ as of 2019. In the United States the wholesale cost of this amount is about US$13.20.

Procaine benzylpenicillin
The wholesale cost in the developing world is about US$0.09–0.18 per day. In the United States a course of treatment costs $100–200.

Prochlorperazine
A dose in the United Kingdom costs the NHS about £0.04 as of 2019. In the United States the wholesale cost of this amount is about US$0.24.

Proguanil
The wholesale cost in the developing world is about US$0.10–0.50 per day.

Promethazine
The wholesale cost of the by mouth formulation is less than US$0.20 per dose as of 2018. In the United Kingdom this dose costs less than £0.25.

Propofol
The wholesale price in the developing world is between 0.61 and 8.50 USD per vial.

Propranolol
The wholesale cost in the developing world is between US$0.24 and US$2.16 per month as of 2014. In the United States it costs about $15 per month at a typical dose.

Propylthiouracil
The wholesale cost in the developing world is about 3.62 USD a month. In the United Kingdom a month costs the NHS about 52.51 pounds. In the United States the wholesale price is 38.34 USD per month.

Protamine sulfate
The wholesale cost in the developing world is about US$2.82–12.20 per vial.

Pyrazinamide
The wholesale cost in the developing world is about US$2.76 per month. In the United States, it costs about US$100 to US$200 per month.

Pyridostigmine
The wholesale cost in the developing world is about US$7.17–65.93 a month. In the United States it costs about US$25–50 per month.

Pyridoxine
The wholesale cost in the developing world is about US$0.59–3.54 per month.

Quetiapine
In the United States, the wholesale cost is about US$12 per month as of 2017. In the United Kingdom, a month's supply costs the NHS about £60 as of 2017.

Cost
In the United States as of 2015, the branded extended-release 400 mg pills cost between US$9.68 and US$23.16 each. In 2017, the short-acting version had a wholesale cost of about US$12 per month. In the United Kingdom, a month's supply, as of 2017, costs the NHS approximately £107.45. This is following an increase of 30 to 70 fold in 2017/2018.

Quinapril
In the United States the wholesale cost of this amount is about US$3.50.

Quinine
The wholesale price in the developing world is about US$1.70 to $3.40 per course of treatment. In the United States a course of treatment is more than $200.

Rabeprazole
A month supply in the United Kingdom costs the NHS about £1 as of 2019. In the United States the wholesale cost of this amount is about 11 USD.

Rabies vaccine
The wholesale cost in the developing world is between 44 and 78 USD for a course of treatment as of 2014. In the United States a course of rabies vaccine is more than 750 USD.

Raloxifene
In the United States the wholesale cost of this amount is about 16 USD.

Raltegravir
The wholesale cost in the developing world is about 50 USD per month. In the United Kingdom it costs the NHS about 472.00 pounds per month.

Ramipril
A month supply in the United Kingdom costs the NHS less than £1 as of 2019. In the United States, the wholesale cost of this amount is about US$2.

Ranitidine
The 2015 wholesale price in the developing world was about US$0.01–0.05 per pill. In the United States it is about $0.05 per dose.

Ranolazine
A month supply in the United Kingdom costs the NHS about 50 £ as of 2019. In the United States the wholesale cost of this amount is about 343 USD.

Regular insulin
The wholesale cost in the developing world is about US$2.39–10.61 per 1,000 iu of regular insulin. In the United Kingdom 1,000 iu costs the NHS £7.48, while in the United States this amount is about $134.00.

Retinol
The wholesale cost in the developing world is about US$0.02–0.30 per 50,000 units. In the United States it is not very expensive.

Rifabutin
The wholesale cost in the developing world is about US$30 a month. In the United States a month of treatment is more than $200.

Rifampicin
The wholesale cost in the developing world is about US$3.90 a month. In the United States a month of treatment is about $120.

Rifampicin/isoniazid/pyrazinamide
The wholesale cost in the developing world is about 3.93 USD a month. In the United Kingdom a month of treatment costs the NHS about 39.51 pounds.

Ringer's lactate solution
The wholesale cost in the developing world is about US$0.60 to US$2.30 per liter.

Risperidone
The wholesale price in the developing world is between US$0.01 and US$0.60 per day as of 2014. The cost for a typical month of medication in the United States is between US$100-200 as of 2015.

Ritonavir
Globally the wholesale cost in the developing world is between US$0.07 and $2.20 per day. In the United States it costs about $9.20–55 per day depending on the dose.

History
In 2003, Abbott (now AbbVie, Inc.) raised the price of a Norvir course from USD $1.71 per day to $8.57 per day, leading to claims of price gouging by patients' groups and some members of Congress.

Rituximab
The wholesale price in the developing world as of 2014 was US$148–496 per 100 mg. In the United Kingdom, the NHS paid approximately £182 per 100 mg in 2015. In the United States, the average price paid was approximately $705 per 100 mg in 2014. The typical treatment for rheumatoid arthritis (1,000 mg IV dose, 2 weeks apart) in the United States would have been $14,100 a month in 2014.

Rivaroxaban
A month supply in the United Kingdom costs the NHS about £50 as of 2019. In the United States, the wholesale cost of this amount is about US$430.

Society and culture
Using rivaroxaban rather than warfarin costs 70 times more, according to Express Scripts Holding Co, the largest U.S. pharmacy benefits manager.

Rizatriptan
A dose in the United Kingdom costs the NHS about 3.10 £ as of 2019. In the United States the wholesale cost of this amount is about US$0.73.

Ropinirole
A month supply in the United Kingdom costs the NHS about 34 £ per month as of 2019. In the United States the wholesale cost of this amount is about US$7.90.

Rosuvastatin
In the United States, the wholesale cost per dose is less than US$0.15. In the United Kingdom, it costs the NHS about £0.65 per dose as of 2018.

Marketing
Annual cost to the UK National Health Service (NHS) in 2018 for 5-40mg rosuvastatin daily was £24-40, compared to £10-20 for 20-80mg simvastatin.

Rotavirus vaccine
The wholesale cost in the developing world is between US$6.96 and $20.66 per dose as of 2014. In the United States it is more than US$200.

<<>>

Rubella vaccine
The wholesale cost of the MMR vaccine in the developing world is 0.24 USD per dose as of 2014. In the United States it costs between 50 and 100 USD.

Salbutamol
The wholesale cost in the developing world of an inhaler which contains 200 doses is between US$1.12 and US$2.64 as of 2014. In the United States, it is between US$25 and US$50 for a typical month's supply.

Cost
The wholesale cost of a 200-dose inhaler is between US$1.12 and US$2.64 in the developing world and GB£1.50 in the United Kingdom. In the United States, a typical month's supply is between $25 and $50.

Saline (medicine)
The wholesale cost in the developing world is about US$0.60–4.20 per liter of normal saline.

Saquinavir
As of 2015 it is not available as a generic medication in the United States and is expensive. The wholesale cost in the developing world is about 4.50 USD per day.

Cost
As of 2015 it is not available as a generic medication and is expensive. The wholesale cost is about 4.50 USD per day.

Senna glycoside
The wholesale cost in the developing world is about 0.01 USD per pill. Sennosides come from the group of plants Senna.

Sertraline
In the United States, the wholesale cost is about US$1.50 per month as of 2018.

Sildenafil
As of 2018 in the United States the wholesale cost is less than US$1 per dose.

Silver sulfadiazine
In the developing world the wholesale cost is between 0.004 and 0.072 USD per gram. In the United States, a course of treatment is generally less than 25 USD.

Simvastatin
The wholesale cost in the developing world is US$0.01 to 0.12 per day. In the United States, it costs between US$0.50 and 1.00 per day.

Society and culture
In the UK in 2008, the typical per-patient cost to the NHS of simvastatin was about £1.50 per month. (40 mg/day costs UK NHS £1.37/month in 2012 )

Sitagliptin
A month's supply in the United Kingdom costs the NHS about £33.26 per month as of 2019. In the United States the wholesale cost of this amount is about US$405.00.

Sitagliptin/metformin
A month supply in the United Kingdom costs the NHS about 33.26 £ as of 2019. In the United States the wholesale cost of this amount is about 433 USD.

Price
A month supply in the United Kingdom costs the NHS about 33.26 £ as of 2019. In the United States the wholesale cost of this amount is about 433 USD. In Denmark 100 tablets (each 1,000 mg) cost over the counter in a pharmacy DKK 62.60 = US$ 9.40 = £7.50, thus a month supply in Denmark costs DKK 37.50 = US$ 5.70 = £ 4.50. The pharmacy buys wholesale at DKK 33.83 = US$ 5.11 = £4.10.

Sodium stibogluconate
The wholesale price in the developing world is 9.66 USD per vial. This gives the cost for a course of treatment at between 12 and 56 USD.

Sodium zirconium cyclosilicate
In the United States it costs about $US24 per dose. In the United Kingdom as of 2019 it costs the NHS about £7.12 per dose.

Solifenacin
A month's supply in the United Kingdom costs the NHS about £27.62 as of 2019. In the United States the wholesale cost of this amount is about 370 USD.

Cost
A 2006 cost-effectiveness study found that 5 mg solifenacin had the lowest cost and highest effectiveness among anticholinergic drugs used to treat overactive bladder in the United States, with an average medical cost per successfully treated patient of $6863 per year. By 2019, with the introduction of generics, the retail cost of a month's supply was down to $20 in the US.

Sotalol
A month supply in the United Kingdom costs the NHS about 5 £ as of 2019. In the United States the wholesale cost of this amount is about US$11.

Spectinomycin
The wholesale cost in the developing world is about US$5 per dose.

Spironolactone
The wholesale cost in the developing world as of 2014 is between US$0.02 and US$0.12 per day. In the United States it costs about US$0.50 per day.

Stavudine
The wholesale cost in the developing world is US$1.86–5.40 per month.

Adverse events
On Monday 30 November 2009, the World Health Organization stated that "[The WHO] recommends that countries phase out the use of Stavudine, or d4T, because of its long-term, irreversible side-effects. Stavudine is still widely used in first-line therapy in developing countries due to its low cost and widespread availability. Zidovudine (AZT) or tenofovir (TDF) are recommended as less toxic and equally effective alternatives."

Streptokinase
The wholesale cost is between 30.00 and US$138.00 per dose as of 2014.

Streptomycin
The wholesale cost in the developing world is between US$0.38 and $4.39 per day. In the United States, a course of treatment costs more than $200.

Sucralfate
In the United States the wholesale cost is about US$0.22 per dose.

Sulfadiazine
The wholesale cost in the developing world is about US$2.70 to 7.32 a month. In the United States, treatment costs more than $200 per month.

Sulfadoxine/pyrimethamine
The wholesale cost in the developing world is about US$0.08–0.36 per day.

Sulfasalazine
The wholesale cost in the developing world is about US$9–33 a month as of 2014. In the United States it costs $25–50 per month for a typical dose.

Cost
The wholesale cost in the developing world is about US$9–33 a month as of 2014. In the United States the average wholesale cost is about $25–50 per month for a typical dose.

Sumatriptan
In the United Kingdom it costs the NHS about £1 per dose as of 2019. In the United States the wholesale cost of this amount is about US$0.60.

Sumatriptan/naproxen sodium
In the United States the combination costs about 50 USD per dose. By themselves a dose of sumatriptan costs about 0.60 USD while a dose of naproxen is about 0.18 USD.

Suxamethonium chloride
The wholesale cost in the developing world is about US$0.45 to US$1.31 a dose.

Tadalafil
In the UK it costs the NHS about 0.80 £ per dose as of 2019. In the United States the wholesale cost of this amount is about US$1.91.

Cost
In the United States, the wholesale cost of tadalafil as of May 2019 is US$1.91 for the 20 mg tabs and US$7.65 for the 2.5 mg tabs. While some health insurance providers cover at least part of the cost (typically limiting the number of doses covered per month), many providers, including those operating under Medicare Part D, do not cover the cost of medications prescribed for erectile dysfunction. In the U.K., a generic version of tadalafil became available in November 2017, reducing its price per pill, and will be available on the NHS. Additionally, Tadacip, manufactured in India by Cipla, is considerably less expensive.

Tafenoquine
In the United States,, a course of treatment costs about US$43. Tafenoquine is related to primaquine.

Tamoxifen
The wholesale price in the developing world is about US$0.07–0.23 per day. In the United States, it costs about $1 per day.

Tamsulosin
In the United States, the wholesale cost per dose is less than 0.10 USD as of 2018. In the United Kingdom, it costs the NHS 0.04 pounds per dose as of 2018.

Telmisartan
A month supply in the United Kingdom costs the NHS less than £2 as of 2019. In the United States the wholesale cost of this amount is about US$10.

Society and culture
A month supply in the United Kingdom costs the NHS less than £2 as of 2019. In the United States the National Average Drug Acquisition Cost of this amount is about US$10 as of 2019.

Telmisartan/amlodipine
In the United States it costs at least US$57 per month as of 2019.

Telmisartan/hydrochlorothiazide
A month of medication costs the NHS about £17 as of 2018. In the United States it costs about US$65 per month as of 2019.

Temazepam
A month supply in the United Kingdom costs the NHS about £1.40 as of 2019. In the United States, the wholesale cost of this amount is about US$1.76.

Tenofovir disoproxil
The wholesale cost in the developing world is between US$3.30 and $29.13 per month. As of 2015 the cost for a typical month of medication in the United States is more than $200.

Terazosin
A month supply in the United Kingdom costs the NHS less than 2 £ as of 2019. In the United States the wholesale cost of this amount is about US$4.50.

Terbinafine
The wholesale cost in the developing world is about 2.20 USD for a 20 g tube. In the United States the price in 1999 was $547 for a 12-week course; this fell to $10 by 2015, after the patent had expired.

Tetanus vaccine
The wholesale cost in the developing world is between 0.17 and 0.65 USD per dose as of 2014. In the United States a course of tetanus vaccine is between 25 and 50 USD.

Tetracaine
The wholesale cost in the developing world is about US$1.34–1.63 per 10 ml bottle. In the United Kingdom the eye drops cost the NHS about 0.49 pounds per dose.

Tetracycline
The wholesale cost in the developing world is about 0.35 to 1.78 USD for a course of treatment. In the United States a course of treatment typically costs less than 25 USD. Tetracycline was originally made from bacteria of the Streptomyces type.

Price
According to data from EvaluatePharma and published in the Boston Globe, the price of tetracycline rose from $0.06 per 250-mg pill in 2013 to $4.06 a pill in 2015. The Globe described the "big price hikes of some generic drugs" as a "relatively new phenomenon" which has left most pharmacists "grappling" with large upswings" in the "costs of generics, with 'overnight' price changes sometimes exceeding 1,000%."

Thalidomide
In the United Kingdom it costs the NHS about £1,194 per month as of 2018. This amount in the United States costs about US$9,236 as of 2019.

Cost
In the United Kingdom it costs the NHS about £1,194 per month as of 2018. This amount in the United States costs about US$9,236 as of 2019.

Thiamazole
A month supply in the United States has a wholesale cost of about US$6.80. It is also available in Europe and Asia.

Thiamine
The wholesale cost in the developing world (as of 2016) is about US$2.17 per one gram vial. In the United States a month's supply of a multivitamin containing thiamine is less than US$25.

Timolol
The wholesale cost in the developing world is about US$0.86–2.29 per 5 ml bottle. In the United States it costs US$25–50 per month.

Tioguanine
The wholesale price in the developing world is about 7.07 USD per 40 mg pill as of 2014. In the United Kingdom this amount costs the NHS about 4.14 pounds.

Tiotropium bromide
In the United States the wholesale cost was about US$13.75 per dose as of 2019. In the United Kingdom a dose costs the NHS about 0.86 pounds as of 2019.

Tizanidine
A month supply in the United Kingdom costs the NHS about 3.45 £ as of 2019. In the United States the wholesale cost of this amount is about US$4.20.

Tolterodine
A month supply costs the NHS about GB£2.09 per month as of 2019. In the United States the wholesale cost of this amount is about US$37.16.

Topiramate
A month supply in the United Kingdom costs the NHS about £1.40 per month as of 2019. In the United States the wholesale cost of this amount is about 4.00 USD.

Torasemide
A month supply in the United Kingdom costs the NHS less than 10 £ as of 2019. In the United States the wholesale cost of this amount is about XXX USD.

Tramadol
In the United States, the wholesale cost is less than US$0.05 per dose as of 2018.

Tranexamic acid
The wholesale cost in the developing world is about 4.38 to US$4.89 for a course of treatment. In the United States, a course of treatment costs between 100 and US$200.

Trastuzumab
, the wholesale price in the developing world is between US$1,800 and US$1,955 per 440 mg vial. In the United Kingdom, a 150 mg vial costs the NHS £407.00.

Costs
Trastuzumab costs about US$70,000 for a full course of treatment, Trastuzumab brought in $327 million in revenue for Genentech in the fourth quarter of 2007. Australia has negotiated a lower price of A$50,000 per course of treatment. Since October 2006, trastuzumab has been made available for Australian women and men with early-stage breast cancer via the Pharmaceutical Benefits Scheme. This is estimated to cost the country over A$470 million for 4–5 years supply of the drug. Roche has changed the trade name of the drug and has re-introduced an affordable version of the same in the Indian market. The new drug named Herclon would cost approximately RS75,000 INR (US$1,200) in the Indian market. On September 16, 2014, Genentech notified hospitals in the United States that, as of October, trastuzumab could only be purchased through their selected specialty drugs distributors not through the usual general line wholesalers. By being forced to purchase through specialty pharmacies, hospitals lost rebates from the big wholesalers and the ability to negotiate cost-minus discounts with their wholesalers.

Travoprost
A 2.5 milliliter bottle in the United Kingdom costs the NHS about 7.30 £ as of 2019. In the United States the wholesale cost of this amount is about US$177.

Trazodone
The cost in the United Kingdom for the NHS is about £7.46 per month as of 2019. In the United States, the wholesale cost is about US$4.53 per month as of 2018.

Triamcinolone
In the United States the wholesale cost is about US$0.06 per gram for the cream.

Tropicamide
The wholesale cost in the developing world is about US$4.19–4.55 per 15 ml bottle. In the United States a course of treatment costs less than $25.

Tuberculin
The wholesale cost in the developing world is about 0.22 USD per dose. In the United States testing costs less than 25 USD.

Typhoid vaccine
The wholesale cost in the developing world is about US$4.44 per dose as of 2014. In the United States they cost $25–50.

Valaciclovir
A month supply in the United Kingdom costs the NHS about £3 as of 2019. In the United States the wholesale cost of this amount is about US$2.80. In 2016 it was the 168th most prescribed medication in the United States with more than 3 million prescriptions.

History
A month supply in the United Kingdom costs the NHS about £3 as of 2019. In the United States the wholesale cost of this amount is about US$2.80.

Valganciclovir
The wholesale price in the developing world is between 30.16 and 52.14 USD per day. In the United States as of 2016 the wholesale costs were about 58.54 USD per day.

Price and patent status
The price of a four-month course of valganciclovir from Roche is about US$8,500 in high-income countries, $6,000 in India. However, the valganciclovir patent was rejected by the Indian Patent Office

Valproate
The wholesale cost in the developing world is about US$0.40 per day as of 2015. In the United States, the wholesale cost is roughly US$1.30 per day as of 2019.

Cost
The wholesale cost in the developing world is about US$0.40 per defined daily dose as of 2015. In the United States, the National Average Drug Acquisition Cost is roughly US$1.30 per day for the short acting formulation as of 2019. The price to a consumer in the United States for this amount is about $US2.30 per day as of 2019. The long acting formulations are more expensive. In the European Union, end-user costs are less than 0.60 EUR for an average daily dose in Germany.

Valsartan
A month supply in the United Kingdom costs the NHS about 5 £ per month as of 2019. In the United States the wholesale cost of this amount is about US$7.50.

Valsartan/hydrochlorothiazide
A month supply in the United Kingdom costs the NHS about 1.85 as of 2019. In the United States the wholesale cost of this amount is about US$4.40.

Vancomycin
The wholesale cost in the developing world of an intravenous dose is about US$1.70 to 6.00. In the United States, the capsules are more expensive than the intravenous solution.

Cost
The wholesale cost of an intravenous dose is about US$1.70 to 6.00. In the United States, the wholesale cost of the pills are about US$300 for a course of treatment as of 2018.

Venlafaxine
In the United States the wholesale cost per dose is less than US$0.20 as of 2018.

Verapamil
The wholesale cost in the developing world is about US$1.71–2.70 per month. In the United States a month of treatment costs $25–50. Long acting formulations exist.

Vilazodone
In the United States the wholesale cost for a month of medication is about 261 USD.

Vinblastine
As of 2014 the wholesale cost in the developing world is about US$7.70 and US$31.70 per dose. In the United Kingdom it costs £13.09 per 10 mg vial.

Vincristine
The wholesale cost in the developing world is between US$1.80 and US$42.60 per dose.

Vinorelbine
The wholesale price in the developing world as of 2014 is between 18.10 and 42.82 USD per 50 mg vial. This amount in the United Kingdom costs the NHS about 139.00 pounds.

Industrial production
In 2017, China produced about 95% of the world supply of ascorbic acid (vitamin C), which is China's most exported vitamin, having total revenue of US$880 million in 2017. Due to pressure on Chinese industry to discontinue burning coal normally used for vitamin C manufacturing, the price of vitamin C rose three-fold in 2016 alone to US$12 per kg.

Voriconazole
The wholesale cost in the United States, as of 2019, is about 9 USD per day.

Vortioxetine
A month supply in the United Kingdom costs the NHS about £27.72 as of 2019. In the United States the wholesale cost of this amount is about 368.40 USD.

Warfarin
The wholesale cost in the developing world is about US$1.12 to 7.20 for a typical month of treatment. In the United States it usually costs less than $25 a month.

Water for injection
The wholesale cost in the developing world is about US$0.03–0.15 per 10 ml vial. In the United Kingdom this amount cost the NHS 0.25 to 1.40 pounds.

Xylometazoline
The wholesale cost in the developing world is about 0.75 USD for a 10 ml bottle. In the United Kingdom that dose costs the NHS about 2.10 pounds.

Yellow fever vaccine
The wholesale price in the developing world is between US$4.30 and US$21.30 per dose as of 2014. In the United States it costs between US$50 and US$100.

Zidovudine
The wholesale cost in the developing world is US$5.10 to $25.60 per month. , the cost for a typical month of medication in the United States was more than $200.

Zinc sulfate (medical use)
The wholesale cost in the developing world is about US$0.01–18 per day. In the United Kingdom ten days of treatment costs the NHS about 4.32 pounds.

Zoledronic acid
The wholesale cost in the developing world is between 5.73 USD and 26.80 USD per vial. In the United Kingdom, as of 2015, a dose costs the NHS about 220 pounds.